Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1B (migalastat)[1] Migalastat[2] Migalastat hydrochloride ,
Migalastat 💬 		[1] GLA 💬 [5] Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬[1] 19 💬
2B / Phuket / 3073/2013-like virus)----[1] 53 💬
3B-Lymphocyte Stimulator (BLyS)----[1] 65 💬
4B-peptide-CRM197 conjugate----[1] 11 💬
5B-STN DBS----[1] 6 💬
6B. lactis B94----[1] 193 💬
7B. theta----[1] 96 💬
8B001----[1] 13 💬
9B001 injection----[1] 13 💬
10B007----[3] 11, 35, 222 💬
11B02BX05----[1] 63 💬
12B03A A07----[1] 97 💬
13B03AC06----[1] 97 💬
14B03BB01----[1] 46 💬
15B2-ASmedic----[1] 97 💬
16B6, B12, L-methylfolate----[1] 6 💬
17B6-Solution----[1] 234 💬
18B: 2 dosis----[1] 97 💬
19Babaodan Capsule----[1] 93 💬
20Bacille Calmette-Guerin vaccine----[1] 13 💬
21Bacille of Calmette-Guerin----[1] 13 💬
22Bacillus clausii[1] Bacillus clausii---[1] 97 💬
23Bacillus coagulans[1] Bacillus coagulans---[1] 6 💬
24Bacillus licheniformis[1] Bacillus licheniformis---[1] 6 💬
25Bacillus Subtilis[1] Bacillus subtilis---[3] 6, 28, 96 💬
26Bacillus subtilis Capsules[1] Bacillus subtilis---[1] 96 💬
27Background PAH Therapy----[1] 86 💬
28Background Treatment----[1] 46 💬
29Baclofen[1] Baclofen[1] Baclofen 💬 [2] GABBR1,
GABBR2 💬 		[8] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬[8] 2, 10, 13, 18, 65, 70, 149, 206 💬
30Baclofen (baclofen Tab. 10mg) treatment[1] Baclofen[1] Baclofen 💬 [2] GABBR1,
GABBR2 💬 		[8] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬[1] 70 💬
31Baclofen 20 mg[1] Baclofen[1] Baclofen 💬 [2] GABBR1,
GABBR2 💬 		[8] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬[1] 13 💬
32Baclofen ER Capsules (GRS) 10 mg[1] Baclofen[1] Baclofen 💬 [2] GABBR1,
GABBR2 💬 		[8] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬[1] 13 💬
33Baclofen ER Capsules (GRS) 20 mg[1] Baclofen[1] Baclofen 💬 [2] GABBR1,
GABBR2 💬 		[8] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬[1] 13 💬
34Baclofen ER Capsules (GRS) 30mg[1] Baclofen[1] Baclofen 💬 [2] GABBR1,
GABBR2 💬 		[8] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬[1] 13 💬
35Baclofen ER Capsules (GRS) 40mg[1] Baclofen[1] Baclofen 💬 [2] GABBR1,
GABBR2 💬 		[8] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬[1] 13 💬
36Baclofen ER Capsules (GRS) 50 mg[1] Baclofen[1] Baclofen 💬 [2] GABBR1,
GABBR2 💬 		[8] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬[1] 13 💬
37Baclofen IR[1] Baclofen[1] Baclofen 💬 [2] GABBR1,
GABBR2 💬 		[8] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬[1] 13 💬
38Baclofen Tablets USP[1] Baclofen[1] Baclofen 💬 [2] GABBR1,
GABBR2 💬 		[8] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬[1] 13 💬
39Baclofen Tablets USP 10 mg[1] Baclofen[1] Baclofen 💬 [2] GABBR1,
GABBR2 💬 		[8] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬[1] 13 💬
40BACLOFENE----[1] 10 💬
41Bacteriophage----[1] 65 💬
42Bacteriophage preparation----[1] 96 💬
43Bacteriotherapy----[2] 96, 97 💬
44Bacteroides thetaiotaomicron[1] Bacteroides thetaiotaomicron---[1] 96 💬
45Bactrim----[1] 299 💬
46BAF312----[2] 13, 50 💬
47BAF312 0,25 mg tablet----[1] 13 💬
48BAF312 0,5 mg tablet----[1] 50 💬
49BAF312 0.25 mg----[1] 50 💬
50BAF312 0.25 mg tablet----[1] 50 💬
51BAF312 0.25mg tablet----[1] 50 💬
52BAF312 0.5 mg----[1] 50 💬
53BAF312 0.50 mg----[1] 50 💬
54BAF312 1 mg----[1] 50 💬
55BAF312 1 mg tablet----[2] 13, 50 💬
56BAF312 1mg----[1] 50 💬
57BAF312 1mg tablet----[1] 50 💬
58BAF312 2 mg----[1] 50 💬
59BAF312 2 mg tablet----[1] 50 💬
60BAF312 2mg----[1] 50 💬
61BAF312 4 mg tablet----[1] 13 💬
62BAF312 4mg tablet----[1] 50 💬
63BAF312 5 mg tablet----[1] 50 💬
64BAF312 hemifumarate----[2] 13, 50 💬
65BAF312A----[1] 13 💬
66BAF312X----[1] 50 💬
67BAFF-R CART----[2] 11, 14 💬
68Bafiertam----[1] 13 💬
69Baitouweng Tang----[1] 97 💬
70Baked Milk----[1] 98 💬
71Balance platform therapy----[1] 13 💬
72Balanced diet----[1] 49 💬
73Balinatunfib[1] Balinatunfib[1] Balinatunfib 💬 [2] TNFRSF1A,
TNFRSF1B 💬 		[35] Adipocytokine signaling pathway, Alcoholic liver disease, Alzheimer disease, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin resistance, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MAPK signaling pathway, NF-kappa B signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TNF signaling pathway, Toxoplasmosis, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, mTOR signaling pathway 💬[2] 96, 97 💬
74Ballon Pulmonary Angioplasty----[1] 88 💬
75Balloon pulmonary angioplasty----[1] 88 💬
76Balloon Pulmonary Angioplasty (BPA)----[1] 88 💬
77Balsalazide[1] Balsalazide[2] Balsalazide disodium ,
Balsalazide 💬 		--[1] 97 💬
78Balsalazide Disodium[1] Balsalazide[2] Balsalazide disodium ,
Balsalazide 💬 		--[1] 97 💬
79Baminercept[1] Baminercept[1] Baminercept 💬 [1] LTB 💬 [3] Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[4] 13, 46, 53, 97 💬
80Baminercept alfa[1] Baminercept[1] Baminercept 💬 [1] LTB 💬 [3] Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 46 💬
81Baminercept alfa (BG9924)[1] Baminercept[1] Baminercept 💬 [1] LTB 💬 [3] Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 46 💬
82Bardoxolone[1] Bardoxolone[1] Bardoxolone 💬 --[7] 66, 67, 84, 85, 86, 218, 222 💬
83Bardoxolone methyl[2] Bardoxolone,
Bardoxolone methyl		[2] Bardoxolone ,
Bardoxolone methyl 💬 		--[7] 66, 67, 84, 85, 86, 218, 222 💬
84Bardoxolone methyl 10 mg[2] Bardoxolone,
Bardoxolone methyl		[2] Bardoxolone ,
Bardoxolone methyl 💬 		--[1] 67 💬
85Bardoxolone methyl 15 mg[2] Bardoxolone,
Bardoxolone methyl		[2] Bardoxolone ,
Bardoxolone methyl 💬 		--[1] 67 💬
86Bardoxolone methyl 20 mg[2] Bardoxolone,
Bardoxolone methyl		[2] Bardoxolone ,
Bardoxolone methyl 💬 		--[1] 67 💬
87Bardoxolone methyl 5 mg[2] Bardoxolone,
Bardoxolone methyl		[2] Bardoxolone ,
Bardoxolone methyl 💬 		--[1] 67 💬
88Bardoxolone methyl capsules[2] Bardoxolone,
Bardoxolone methyl		[2] Bardoxolone ,
Bardoxolone methyl 💬 		--[4] 66, 67, 86, 222 💬
89Bardoxolone methyl oral capsule[2] Bardoxolone,
Bardoxolone methyl		[2] Bardoxolone ,
Bardoxolone methyl 💬 		--[1] 67 💬
90BARDOXOLONE METHYL, CDDO-Me, CDDO-Methyl Ester, NSC 713200, Chemical Name: Oleana-1,9(11)-dien-28-oic acid, 2-cyano-3,12-dioxo-, methyl ester[2] Bardoxolone,
Bardoxolone methyl		[2] Bardoxolone ,
Bardoxolone methyl 💬 		--[1] 86 💬
91Bardoxolone Metile[1] Bardoxolone[1] Bardoxolone 💬 --[1] 67 💬
92Baricinitib----[1] 49 💬
93Baricitinib[1] Baricitinib[1] Baricitinib 💬 [2] JAK1,
JAK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[24] 2, 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬
94Baricitinib (LY3009104) 4 mg[1] Baricitinib[1] Baricitinib 💬 [2] JAK1,
JAK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[2] 46, 84 💬
95Baricitinib 2 MG[1] Baricitinib[1] Baricitinib 💬 [2] JAK1,
JAK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[3] 46, 53, 63 💬
96Baricitinib 2 MG [Olumiant][1] Baricitinib[1] Baricitinib 💬 [2] JAK1,
JAK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[2] 63, 162 💬
97Baricitinib 4 MG[1] Baricitinib[1] Baricitinib 💬 [2] JAK1,
JAK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[2] 40, 46 💬
98Baricitinib 4 MG Oral Tablet[1] Baricitinib[1] Baricitinib 💬 [2] JAK1,
JAK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 46 💬
99Baricitinib blinded[1] Baricitinib[1] Baricitinib 💬 [2] JAK1,
JAK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 46 💬
100Baricitinib Oral Tablet [Olumiant][1] Baricitinib[1] Baricitinib 💬 [2] JAK1,
JAK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 46 💬
101Baricitinib treatment[1] Baricitinib[1] Baricitinib 💬 [2] JAK1,
JAK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 46 💬
102Baricitinib, olumiant®[1] Baricitinib[1] Baricitinib 💬 [2] JAK1,
JAK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 46 💬
103Barium[1] Barium---[5] 2, 6, 19, 97, 98 💬
104Barley[1] Barley---[1] 74 💬
105BARNASCAN----[1] 88 💬
106Barzolvolimab[1] Barzolvolimab[1] Barzolvolimab 💬 [1] KIT 💬 [11] Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬[1] 98 💬
107Bascial prescription plus or minus herbs depend on symptoms----[1] 97 💬
108Base-edited hematopoietic stem and progenitor cells----[1] 65 💬
109Baseline disease modifying therapies (DMTs)----[1] 13 💬
110Baseline Glucocorticoid Therapy----[1] 222 💬
111Baseline Treatment----[1] 13 💬
112Baseline WLL----[1] 229 💬
113Basic Fibroblast Growth Factor[1] Basic Fibroblast Growth Factor---[1] 47 💬
114Basic treatment----[1] 51 💬
115Basic treatment: sulperazone + ursodeoxycholic acid + compound glycyrrhizin + methylprednisolone + vitamin AD , D , E , K + imipenem or meropenem[4] Imipenem,
Meropenem,
Methylprednisolone,
Ursodeoxycholic acid		[7] Imipenem ,
Methylprednisolone ,
Ursodiol ,
Methylprednisolone acetate ,
Meropenem ,
Imipenem ,
Meropenem 💬 		[2] NR1H4,
NR3C1 💬 		[2] Bile secretion, Neuroactive ligand-receptor interaction 💬[1] 296 💬
116Basiliximab[1] Basiliximab[1] Basiliximab 💬 [1] IL2RA 💬 [11] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[5] 2, 50, 97, 222, 228 💬
117BASIMGLURANT[1] Basimglurant[1] Basimglurant 💬 --[1] 158 💬
118BASIMGLURANT    [1] Basimglurant[1] Basimglurant 💬 --[1] 158 💬
119BASSADO----[1] 23 💬
120BASSADO - 100 MG COMPRESSE 10 COMPRESSE----[1] 28 💬
121BASSADO 10CPS 100MG----[1] 23 💬
122BAT1406----[1] 271 💬
123BAT1806[1] Tocilizumab[1] Tocilizumab 💬 [1] IL6R 💬 [11] Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 46 💬
124BAT1806 injection----[1] 46 💬
125BAT4406F----[2] 13, 222 💬
126BAT4406F Injection----[1] 13 💬
127Batoclimab[1] Batoclimab[1] Batoclimab 💬 --[2] 11, 14 💬
128Batoclimab 340 mg SC bi-weekly[1] Batoclimab[1] Batoclimab 💬 --[1] 11 💬
129Batoclimab 340 mg SC weekly[1] Batoclimab[1] Batoclimab 💬 --[2] 11, 14 💬
130Batoclimab 680 mg SC weekly[1] Batoclimab[1] Batoclimab 💬 --[1] 11 💬
131Batoclimab 680 milligrams (mg) subcutaneous (SC) weekly[1] Batoclimab[1] Batoclimab 💬 --[1] 14 💬
132Bavisant[1] Bavisant[1] Bavisant 💬 [1] HRH3 💬 [2] Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[1] 6 💬
133Bavisant dihydrochloride monohydrate[1] Bavisant[1] Bavisant 💬 [1] HRH3 💬 [2] Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[1] 6 💬
134BAVISANT HYDROCHLORIDE MONOHYDRATE[1] Bavisant[1] Bavisant 💬 [1] HRH3 💬 [2] Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[1] 6 💬
135Bawei Shenqi Pill----[1] 271 💬
136BAX930----[1] 64 💬
137BAX930 - RECOMBINANT HUMAN ADAMTS13[1] Apadamtase alfa[2] Apadamtase alfa ,
Apadamtase alfa and cinaxadamtase alfa 💬 		[1] ADAMTS13 💬 [1] Platelet activation 💬[1] 64 💬
138BAX930 or SHP655----[1] 64 💬
139BAX930 or SHP655 or TAK755----[1] 64 💬
140BAY 3401016----[1] 218 💬
141BAY 59-7939----[2] 48, 210 💬
142BAY 63-2521----[2] 86, 88 💬
143BAY 63-2521 0.06 %----[1] 86 💬
144BAY 63-2521 0.3 %----[1] 86 💬
145BAY 63-2521 coated tablets 0.5 mg----[2] 86, 88 💬
146BAY 63-2521 coated tablets 1 mg----[2] 86, 88 💬
147BAY 63-2521 coated tablets 1.5 mg----[2] 86, 88 💬
148BAY 63-2521 coated tablets 2 mg----[2] 86, 88 💬
149BAY 63-2521 coated tablets 2.5 mg----[2] 86, 88 💬
150BAY 63-2521 IR coated tablet 1.0 mg----[1] 88 💬
151BAY 63-2521 IR coated tablet 1.5 mg----[1] 88 💬
152BAY 63-2521 IR coated tablet 2.0 mg----[1] 88 💬
153BAY 63-2521 IR coated tablet 2.5 mg----[1] 88 💬
154BAY 63-2521 IR tablet 0.5 mg----[1] 88 💬
155BAY 63-2521 IR tablet 1.0 mg----[1] 88 💬
156BAY 63-2521 IR tablet 1.5 mg----[1] 88 💬
157BAY 63-2521 IR tablet 2.0 mg----[1] 88 💬
158BAY 63-2521 IR tablet 2.5 mg----[1] 88 💬
159BAY 63-2521 IR tablets 0.5 mg----[1] 86 💬
160BAY 63-2521 IR tablets 1 mg----[1] 86 💬
161BAY 63-2521 IR tablets 1.0 mg----[1] 86 💬
162BAY 63-2521 IR tablets 1.5 mg----[1] 86 💬
163BAY 63-2521 IR tablets 2.0 mg----[1] 86 💬
164BAY 63-2521 IR tablets 2.5 mg----[1] 86 💬
165BAY 63-2521 Tablet----[1] 86 💬
166BAY 63-2521 tablets 0.5 mg----[2] 86, 88 💬
167BAY 63-2521 tablets 1 mg----[2] 86, 88 💬
168BAY 63-2521 tablets 1.5 mg----[2] 86, 88 💬
169BAY 63-2521 tablets 2 mg----[2] 86, 88 💬
170BAY 63-2521 tablets 2.5 mg----[2] 86, 88 💬
171BAY 79-4998----[1] 13 💬
172BAY 80-6946----[1] 121 💬
173BAY 85-8501----[1] 299 💬
174BAY q 3939----[1] 299 💬
175Bay Q 6256----[1] 86 💬
176BAY1237592----[2] 86, 88 💬
177BAY3723113----[1] 58 💬
178BAY63-2521----[3] 51, 86, 299 💬
179BAY85-8501----[1] 299 💬
180BAY86-5046----[1] 13 💬
181BAY86-5046_Interferon-beta-1b----[1] 13 💬
182BAYQ3939----[1] 299 💬
183Bazedoxifene[1] Bazedoxifene[1] Bazedoxifene acetate 💬 [2] ESR1,
ESR2 💬 		[10] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[1] 13 💬
184Bazedoxifene Acetate[2] Acetate,
Bazedoxifene		[1] Bazedoxifene acetate 💬 [2] ESR1,
ESR2 💬 		[10] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[1] 13 💬
185BB-301[1] BB-301---[1] 113 💬
186BB-TL1A-VIAL-HLE----[1] 97 💬
187BBM-P002----[1] 6 💬
188BBP-418----[1] 113 💬
189BBP-418 (ribitol)[1] Ribitol[1] Ribitol 💬 --[1] 113 💬
190BBP-671[1] BBP-671---[2] 245, 246 💬
191BBP-812[1] BBP-812---[1] 307 💬
192BBR 2778----[2] 11, 13 💬
193BBT-401-1S----[1] 97 💬
194BBT-401-1S, Multiple doses----[1] 97 💬
195BBT-401-1S, Single dose----[1] 97 💬
196BBT-877[1] BBT-877---[1] 85 💬
197BBT-877, Multiple doses[1] BBT-877---[1] 85 💬
198BBT-877, Single dose[1] BBT-877---[1] 85 💬
199BC006----[1] 85 💬
200BC7353----[1] 65 💬
201BCD-033 (interferon beta 1a)----[1] 13 💬
202BCD-054 180 mcg----[1] 13 💬
203BCD-054 240 mcg----[1] 13 💬
204BCD-055----[2] 46, 271 💬
205BCD-063----[1] 13 💬
206BCD-085----[2] 93, 271 💬
207BCD-089----[1] 46 💬
208BCD-089, 162 mg, s/c, q2w----[1] 46 💬
209BCD-089, 162 mg, s/c, qw----[1] 46 💬
210BCD-132----[1] 13 💬
211BCD-132, 125 mg----[1] 13 💬
212BCD-132, 500 mg----[1] 13 💬
213BCD-148----[1] 62 💬
214BCD-256----[1] 49 💬
215BCG TICE Vaccine----[1] 299 💬
216BCG20-0134----[1] 13 💬
217BCMA bispecific----[1] 28 💬
218BCMA CAR-T or CD19 CAR-T or CD19×BCMA----[1] 97 💬
219BCMA-CD19 CAR-T therapy----[6] 48, 49, 51, 53, 56, 64 💬
220BCMA-CD19 cCAR T cells----[1] 63 💬
221BCMA/CD19 CAR-T cells----[2] 49, 53 💬
222BCMA/CD70 CAR-T cells----[1] 49 💬
223BCMA/CD70-targetd CAR-T----[4] 50, 51, 53, 107 💬
224BCT301----[3] 48, 51, 53 💬
225BCX10013[1] BCX10013---[1] 62 💬
226BCX17725----[1] 160 💬
227BCX4161[1] Avoralstat---[1] 65 💬
228BCX7353[1] Berotralstat[2] Berotralstat ,
Berotralstat hydrochloride 💬 		[1] KLKB1 💬 [1] Complement and coagulation cascades 💬[1] 65 💬
229BCX7353 + digoxin[1] Digoxin[1] Digoxin 💬 [4] ATP1A1,
ATP1A2,
ATP1A3,
ATP1A4 💬 		[19] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Bile secretion, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cytoskeleton in muscle cells, Endocrine and other factor-regulated calcium reabsorption, Gastric acid secretion, Insulin secretion, Mineral absorption, Pancreatic secretion, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Thyroid hormone signaling pathway, Thyroid hormone synthesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 65 💬
230BCX7353 and probes----[1] 65 💬
231BCX7353 capsules----[1] 65 💬
232BCX9930----[4] 62, 66, 222, 223 💬
233BCX9930 hydrochloride----[4] 62, 66, 222, 223 💬
234BCX9930 monotherapy----[1] 62 💬
235BDHK-2009 Tablets----[2] 96, 97 💬
236BDMARD----[1] 46 💬
237BDMARD treatment----[1] 271 💬
238BDMARD withdrawal (etanercept, adalimumab, infliximab, certolizumab, golimumab, tozilizumab, abatacept)[5] Abatacept,
Adalimumab,
Etanercept,
Golimumab,
Infliximab		[5] Etanercept ,
Adalimumab ,
Infliximab ,
Abatacept ,
Golimumab 💬 		[4] CD80,
CD86,
LTA,
TNF 💬 		[74] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cell adhesion molecule (CAM) interaction, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, IgSF CAM signaling, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Adenovirus, Yersinia infection, mTOR signaling pathway 💬[1] 46 💬
239BDMARDS----[1] 46 💬
240BEAM Regimen----[1] 13 💬
241BEAM-302----[1] 231 💬
242Bean[1] Bean---[1] 96 💬
243Beclometasone----[1] 97 💬
244Beclometasone dipropionate----[2] 85, 97 💬
245Beclomethasone dipropionate[1] Beclomethasone dipropionate[3] Beclomethasone dipropionate ,
Beclometasone ,
Beclomethasone dipropionate monohydrate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 97, 98 💬
246Beclomethasone diproprionate----[1] 97 💬
247Bedaquiline[1] Bedaquiline[2] Bedaquiline ,
Bedaquiline fumarate 💬 		--[1] 299 💬
248Bee venom----[1] 6 💬
249Bee venom pharmacopuncture----[1] 70 💬
250Beet[1] Beet---[1] 340 💬
251Beet-it Juice[1] Beet---[1] 340 💬
252Beetainterferoni -1a----[1] 13 💬
253Beetroot juice----[2] 67, 86 💬
254BEFIRADOL[1] Befiradol---[1] 6 💬
255BEFIZAL L.P. 400 mg, comprimé enrobé à libération prolongée----[1] 94 💬
256Begelomab[1] Begelomab---[1] 50 💬
257Behavioral: 24 hour diet recall----[1] 86 💬
258Behavioral: 50 patients will have a Free Choice between Filgotinib and anti TNF[1] Filgotinib[2] Filgotinib ,
Filgotinib maleate 💬 		[4] JAK1,
JAK2,
JAK3,
TYK2 💬 		[39] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 46 💬
259Behavioral: 6 months weight resistance and balance program----[1] 13 💬
260Behavioral: 60-minutes of steady state exercise----[1] 265 💬
261Behavioral: AbbVie Care 2.0----[4] 46, 96, 97, 271 💬
262Behavioral: Acceptance and Commitment Therapy----[1] 97 💬
263Behavioral: Activity monitoring----[1] 86 💬
264Behavioral: Adherence counseling----[1] 13 💬
265Behavioral: Administration of probiotic (L. rhamnosus and L. acidophilus)----[1] 97 💬
266Behavioral: Aerobic Exercise----[2] 240, 299 💬
267Behavioral: Aerobic Training----[1] 18 💬
268Behavioral: anal dilation----[1] 291 💬
269Behavioral: assessment during the transition between OFF-levodopa (i.e. withdrawal of levodopa phase) and ON-levodopa (i.e. effect of Levodopa phase)states[1] Levodopa[1] Levodopa 💬 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		[13] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
270Behavioral: Assessment of cognition----[1] 6 💬
271Behavioral: Assessment of depression----[1] 6 💬
272Behavioral: Assessment of disability----[1] 13 💬
273Behavioral: Assessment of impact of MS on cognition----[1] 13 💬
274Behavioral: Assessment of motor and non-motors symptoms of PD Evaluation of hyper- and hypodopaminergic behaviors----[1] 6 💬
275Behavioral: Assessment of quality of life----[2] 6, 97 💬
276Behavioral: Assessment of severity of ICD (impulse control disorders)----[1] 6 💬
277Behavioral: Assessment of severity of Parkinson Disease----[1] 6 💬
278Behavioral: Assessments in ON and OFF levodopa state[1] Levodopa[1] Levodopa 💬 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		[13] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
279Behavioral: Balance & Strengthening Exercises----[1] 6 💬
280Behavioral: Balance exercise----[1] 299 💬
281Behavioral: Balance targeted exercises----[1] 13 💬
282Behavioral: Balance Training----[3] 6, 13, 18 💬
283Behavioral: Balance training by means of conventional rehabilitation----[1] 18 💬
284Behavioral: Balance training over stabilometric platform----[1] 18 💬
285Behavioral: Behavioral Counseling----[1] 97 💬
286Behavioral: Behavioral health consultation/therapy----[1] 226 💬
287Behavioral: Blood flow restriction----[1] 149 💬
288Behavioral: Blood pressure intervention arm----[1] 46 💬
289Behavioral: Brisk walking and balance training----[1] 6 💬
290Behavioral: Cannabis questionnaire----[2] 46, 271 💬
291Behavioral: Cascade screening----[1] 79 💬
292Behavioral: CBT and sleep hygiene----[1] 6 💬
293Behavioral: CHDR Monitoring Remotely (MORE)----[1] 113 💬
294Behavioral: Childhood Health Assessment Questionnaire----[1] 50 💬
295Behavioral: Clinical Assessment----[1] 6 💬
296Behavioral: Clinical characteristics of AMS patients----[1] 17 💬
297Behavioral: Close follow-up----[3] 57, 58, 59 💬
298Behavioral: Cognitive and Behavioral experimental tasks----[1] 127 💬
299Behavioral: colonic lavage----[1] 291 💬
300Behavioral: Combined balance and brisk walking training----[1] 6 💬
301Behavioral: Completion of a questionnaire on compliance with anticoagulant treatment----[1] 48 💬
302Behavioral: Completion of a questionnaire on satisfaction with treatment anticoagulant----[1] 48 💬
303Behavioral: Complex task practice----[1] 6 💬
304Behavioral: Compliance questionnaire----[1] 84 💬
305Behavioral: Comprehensive rehabilitation----[1] 6 💬
306Behavioral: Concurrent exercise training----[1] 113 💬
307Behavioral: Conservative Measures for Orthostatic Hypotension----[2] 6, 17 💬
308Behavioral: conservative treatment----[1] 291 💬
309Behavioral: Control Group Typically Developing----[1] 113 💬
310Behavioral: Conventional Balance exercise----[1] 6 💬
311Behavioral: Cycling Intervention----[1] 6 💬
312Behavioral: Dexterity----[1] 6 💬
313Behavioral: Diet----[2] 113, 265 💬
314Behavioral: Diet and water adjustment[1] Water[1] Water 💬 --[1] 67 💬
315Behavioral: Dietary Counseling----[1] 46 💬
316Behavioral: Dietary guidance----[1] 46 💬
317Behavioral: Dietary recommendations----[1] 46 💬
318Behavioral: Direct contact of family members for cascade screening of relevant variants----[1] 79 💬
319Behavioral: Duchenne Muscular Dystrophy group with Deflazacort[1] Deflazacort[1] Deflazacort 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 113 💬
320Behavioral: Duchenne Muscular Dystrophy group with Prednisone/Predisolone[1] Prednisone[1] Prednisone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 113 💬
321Behavioral: Duchenne Muscular Dystrophy group without Corticosteroids therapy----[1] 113 💬
322Behavioral: E-learning----[1] 86 💬
323Behavioral: early rehabilitation guidance----[3] 57, 58, 59 💬
324Behavioral: Eating----[1] 193 💬
325Behavioral: ECOCAPTURE----[1] 127 💬
326Behavioral: Environmental Decontamination----[1] 299 💬
327Behavioral: Evaluation about depression cognition----[1] 17 💬
328Behavioral: Evaluations about motor abilities, depression, cognition and lifestyle----[1] 17 💬
329Behavioral: exclusion diet----[1] 96 💬
330Behavioral: Exercise----[6] 6, 46, 113, 265, 299, 344 💬
331Behavioral: Exercise Intervention----[1] 97 💬
332Behavioral: Exercise Training----[1] 265 💬
333Behavioral: Exercise Training on standard steroid regimen----[1] 113 💬
334Behavioral: Exercise-based behavioral therapy----[1] 6 💬
335Behavioral: Flexibility and postural exercise----[1] 299 💬
336Behavioral: Flexibility and strengthening exercise----[1] 6 💬
337Behavioral: Functional Balance Intervention----[1] 13 💬
338Behavioral: Gait and balance----[1] 6 💬
339Behavioral: gait and balance training program----[1] 6 💬
340Behavioral: Gait and balance training with dual-task (six weeks)----[1] 6 💬
341Behavioral: Gait and balance training with dual-task (twelve weeks: 6 +6)----[1] 6 💬
342Behavioral: Gait and balance training with dual-task + action observation and motor imagery (six weeks)----[1] 6 💬
343Behavioral: Gait and balance training with dual-task + action observation and motor imagery (twelve weeks: 6 + 6)----[1] 6 💬
344Behavioral: Habitual Diet----[1] 97 💬
345Behavioral: Healthy age-matched controls----[1] 6 💬
346Behavioral: heart health educational program----[1] 49 💬
347Behavioral: High-Intensity Aerobic Exercise Prior to Balance Training----[1] 18 💬
348Behavioral: High/Low Sitosterol----[1] 260 💬
349Behavioral: Home administration----[1] 77 💬
350Behavioral: Home-based balance training----[1] 13 💬
351Behavioral: Hypnosis----[1] 96 💬
352Behavioral: ICM_APATHY_TASKS----[1] 127 💬
353Behavioral: Increased dietary intake of salmon or cod----[1] 97 💬
354Behavioral: International Physical Activity Questionnaire Short Form (IPAQ-SF)----[1] 86 💬
355Behavioral: lavender oil[1] Lavender oil[1] Lavender oil 💬 --[1] 13 💬
356Behavioral: learning----[1] 13 💬
357Behavioral: Levodopa or acupuncture[1] Levodopa[1] Levodopa 💬 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		[13] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
358Behavioral: Lifestyle----[1] 58 💬
359Behavioral: Lifestyle modifications----[1] 298 💬
360Behavioral: Low Histamine-Based Modified Mediterranean Diet[1] Histamine[3] Histamine dihydrochloride ,
Histamine phosphate ,
Histamine 💬 		[4] HRH1,
HRH2,
HRH3,
HRH4 💬 		[5] Calcium signaling pathway, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[1] 13 💬
361Behavioral: Low resistance exercise intervention----[1] 86 💬
362Behavioral: Low-Intensity Exercise Prior to Balance Training----[1] 18 💬
363Behavioral: Low-load resistance training with blood flow restriction----[1] 6 💬
364Behavioral: Maintenance of specific diet----[1] 79 💬
365Behavioral: Medical Marijuana----[1] 13 💬
366Behavioral: meditation----[1] 13 💬
367Behavioral: Meditation, Prayer, Talk Therapy, Affirmations, Journaling, etc.----[2] 2, 4 💬
368Behavioral: Mediterranean diet----[2] 96, 97 💬
369Behavioral: Mediterranean-Ketogenic Diet----[1] 6 💬
370Behavioral: Memory----[1] 6 💬
371Behavioral: MIND Diet (Mediterranean-DASH Intervention for Neurodegenerative Delay)----[1] 13 💬
372Behavioral: Modified Paleolithic Elimination diet----[1] 13 💬
373Behavioral: MOntreal Cognitive Assessment (MoCA)----[1] 17 💬
374Behavioral: Motivational Counseling----[1] 79 💬
375Behavioral: Motivational Interviewing----[1] 13 💬
376Behavioral: Multicomponent balance intervention consisting of four components including dual-tasking, functional strength, vestibular and dynamic balance.----[1] 13 💬
377Behavioral: Multicomponent Lexical Retrieval Cascade Training----[1] 127 💬
378Behavioral: Multicomponent Video Implemented Script Training in Aphasia----[1] 127 💬
379Behavioral: Neuro-psychological Assessment----[1] 240 💬
380Behavioral: Neurocognitive testing----[1] 19 💬
381Behavioral: OM Meditation----[1] 6 💬
382Behavioral: Other Academic sham tutoring----[1] 34 💬
383Behavioral: Parent version of the Child Health Questionnaire (CHQ)----[1] 50 💬
384Behavioral: Participant open-response writing----[1] 6 💬
385Behavioral: Participant self-assessment surveys----[1] 6 💬
386Behavioral: passive leg raising----[1] 86 💬
387Behavioral: Patient questionnaires----[1] 298 💬
388Behavioral: Pelvic floor muscle exercise-based behavioral therapy----[1] 6 💬
389Behavioral: phenylalanine restricted diet[1] Phenylalanine[1] Phenylalanine 💬 --[1] 240 💬
390Behavioral: Phonation----[1] 6 💬
391Behavioral: Physical Exercise Program----[1] 49 💬
392Behavioral: Physical Therapy----[2] 6, 13 💬
393Behavioral: Physician-prescribed Exercise Programme----[1] 97 💬
394Behavioral: PICC or other Central line placement----[1] 19 💬
395Behavioral: Protein and calorie controlled diet----[1] 251 💬
396Behavioral: Psychosocial intervention----[1] 6 💬
397Behavioral: quality of life assessment----[1] 81 💬
398Behavioral: Quality of Life Questionnaire (emPHasis 10)----[1] 86 💬
399Behavioral: Quality of Life questionnaires----[2] 13, 97 💬
400Behavioral: Questionnaire----[3] 46, 51, 329 💬
401Behavioral: Questionnaires----[3] 28, 49, 84 💬
402Behavioral: Questionnaires and Clinical Assessments----[1] 6 💬
403Behavioral: reading tutoring intervention----[1] 34 💬
404Behavioral: Reduced Sulfur diet----[1] 97 💬
405Behavioral: Regular exercise----[1] 113 💬
406Behavioral: Rehabilitation therapy----[1] 6 💬
407Behavioral: Resistance Exercise----[2] 240, 299 💬
408Behavioral: Resistance Training----[1] 6 💬
409Behavioral: respiratory and exercise therapy----[1] 88 💬
410Behavioral: respiratory and exercise therapy with supplemental oxygen[1] Oxygen[1] Oxygen 💬 --[1] 88 💬
411Behavioral: Restricted phenylalanine diet[1] Phenylalanine[1] Phenylalanine 💬 --[1] 240 💬
412Behavioral: Role of dopamine[1] Dopamine[2] Dopamine hydrochloride ,
Dopamine 💬 		[5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		[13] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
413Behavioral: self massage----[1] 13 💬
414Behavioral: SIT Scoring----[1] 2 💬
415Behavioral: six-foods elimination diet----[1] 98 💬
416Behavioral: Sleep quality and physical activity----[1] 13 💬
417Behavioral: Smoking----[1] 13 💬
418Behavioral: smoking and alcohol assumption----[1] 298 💬
419Behavioral: Speech Intelligibility Test (SIT)----[1] 2 💬
420Behavioral: Split-belt treadmill training----[1] 6 💬
421Behavioral: Static balance exercise----[1] 6 💬
422Behavioral: Step Tracking----[1] 13 💬
423Behavioral: stretching----[2] 6, 13 💬
424Behavioral: Structured wellness care----[1] 6 💬
425Behavioral: Symptom diary----[1] 65 💬
426Behavioral: Tai chi----[1] 18 💬
427Behavioral: Targeted Nursing Care----[1] 222 💬
428Behavioral: Telephone-based Cognitive Behavioral Therapy----[1] 13 💬
429Behavioral: The M.D. Anderson Symptom Inventory (MDASI)----[1] 28 💬
430Behavioral: Time Restricted Olive Oil Based (TROO) Ketogenic Diet[1] Olive oil[1] Olive oil 💬 --[1] 13 💬
431Behavioral: Tobacco Treatment Specialist (TTS) intervention----[1] 299 💬
432Behavioral: Traditional Balance Exercise Training (BAL-EX)----[1] 13 💬
433Behavioral: Traditional healthy nutrition program specific to Turkey[1] Turkey---[1] 13 💬
434Behavioral: Traditional Mediterranean Diet----[1] 13 💬
435Behavioral: Unsupervised exercise----[1] 299 💬
436Behavioral: Upper limb exercise----[1] 6 💬
437Behavioral: Usual diet with Dietary Guidelines for Americans Diet information----[1] 13 💬
438Behavioral: Voice, Speech and Language Analysis----[1] 6 💬
439Behavioral: Water reduction at home[1] Water[1] Water 💬 --[2] 72, 225 💬
440Behavioral: Water Tracking[1] Water[1] Water 💬 --[1] 13 💬
441Behavioral: Withings Blood Pressure Monitor----[1] 113 💬
442Behavioral: Withings Body+ scale----[1] 113 💬
443Behavioral: Withings Steel HR----[1] 113 💬
444Belantamab mafodotin[1] Belantamab mafodotin[1] Belantamab mafodotin 💬 [10] TNFRSF17,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		[14] Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, IgSF CAM signaling, Intestinal immune network for IgA production, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬[2] 28, 63 💬
445Belantamab mafodotin 1.0 mg/kg (12 weeks)[1] Belantamab mafodotin[1] Belantamab mafodotin 💬 [10] TNFRSF17,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		[14] Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, IgSF CAM signaling, Intestinal immune network for IgA production, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬[1] 28 💬
446Belantamab mafodotin 1.4 mg/kg (12 weeks)[1] Belantamab mafodotin[1] Belantamab mafodotin 💬 [10] TNFRSF17,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		[14] Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, IgSF CAM signaling, Intestinal immune network for IgA production, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬[1] 28 💬
447Belantamab mafodotin 1.9 mg/kg (12 weeks)[1] Belantamab mafodotin[1] Belantamab mafodotin 💬 [10] TNFRSF17,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		[14] Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, IgSF CAM signaling, Intestinal immune network for IgA production, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬[1] 28 💬
448Belantamab mafodotin 1.9 mg/kg (8 weeks)[1] Belantamab mafodotin[1] Belantamab mafodotin 💬 [10] TNFRSF17,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		[14] Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, IgSF CAM signaling, Intestinal immune network for IgA production, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬[1] 28 💬
449Belantamab mafodotin 2.5 mg/kg (8 weeks)[1] Belantamab mafodotin[1] Belantamab mafodotin 💬 [10] TNFRSF17,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		[14] Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, IgSF CAM signaling, Intestinal immune network for IgA production, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬[1] 28 💬
450Belantamab mafodotin every 8 weeks or 12 weeks as determined by Part 1 recommended dosages[1] Belantamab mafodotin[1] Belantamab mafodotin 💬 [10] TNFRSF17,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		[14] Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, IgSF CAM signaling, Intestinal immune network for IgA production, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬[1] 28 💬
451Belatacept[1] Belatacept[1] Belatacept 💬 [2] CD80,
CD86 💬 		[14] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬[1] 46 💬
452Belcesiran[1] Belcesiran---[1] 231 💬
453BELIMUMAB[1] Belimumab[1] Belimumab 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[17] 11, 13, 43, 44, 46, 48, 49, 50, 51, 53, 63, 66, 95, 222, 223, 296, 300 💬
454Belimumab (GSK1550188)[1] Belimumab[1] Belimumab 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
455Belimumab 1 mg/kg[1] Belimumab[1] Belimumab 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[2] 46, 49 💬
456Belimumab 10 mg[1] Belimumab[1] Belimumab 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[2] 222, 223 💬
457Belimumab 10 mg/kg[1] Belimumab[1] Belimumab 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[3] 43, 46, 49 💬
458Belimumab 10 mg/kg plus standard therapy[1] Belimumab[1] Belimumab 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
459Belimumab 100 mg SC[1] Belimumab[1] Belimumab 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
460Belimumab 10mg/kg[1] Belimumab[1] Belimumab 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
461Belimumab 200 mg SC[1] Belimumab[1] Belimumab 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
462Belimumab 200 mg/mL[1] Belimumab[1] Belimumab 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
463Belimumab 4 mg/kg[1] Belimumab[1] Belimumab 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[2] 46, 49 💬
464Belimumab Auto-Injector [Benlysta][1] Belimumab[1] Belimumab 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 95 💬
465Belimumab autoinjector[1] Belimumab[1] Belimumab 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
466Belimumab for IV[1] Belimumab[1] Belimumab 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
467Belimumab for SC[1] Belimumab[1] Belimumab 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
468Belimumab in SLE patients / Rituximab in RA patients[2] Belimumab,
Rituximab		[2] Rituximab ,
Belimumab 💬 		[2] MS4A1,
TNFSF13B 💬 		[5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[2] 46, 49 💬
469Belimumab Injection[1] Belimumab[1] Belimumab 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
470Belimumab Injection [Benlysta][1] Belimumab[1] Belimumab 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
471Belimumab or benlysta[1] Belimumab[1] Belimumab 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
472Belimumab plus Early Vaccination[1] Belimumab[1] Belimumab 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
473Belimumab plus Late Vaccination[1] Belimumab[1] Belimumab 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
474Belimumab Powder for solution for infusion [120 mg/vial][1] Belimumab[1] Belimumab 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
475Belimumab Solution for injection (200 mg/ml)[1] Belimumab[1] Belimumab 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
476Belimumab+SOC[1] Belimumab[1] Belimumab 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 48 💬
477Beloranib[1] Beloranib---[1] 193 💬
478Belumosudil[1] Belumosudil[2] Belumosudil ,
Belumosudil mesylate 💬 		[1] ROCK2 💬 [23] Adherens junction, Axon guidance, Cadherin signaling, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[3] 51, 85, 228 💬
479Belumosudil (KD025)[1] Belumosudil[2] Belumosudil ,
Belumosudil mesylate 💬 		[1] ROCK2 💬 [23] Adherens junction, Axon guidance, Cadherin signaling, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 51 💬
480Bemdaneprocel----[1] 6 💬
481Bempedoic acid[1] Bempedoic acid[1] Bempedoic acid 💬 [1] ACLY 💬 [1] Citrate cycle (TCA cycle) 💬[2] 67, 79 💬
482Bempedoic Acid 180 MG Oral Tablet[1] Bempedoic acid[1] Bempedoic acid 💬 [1] ACLY 💬 [1] Citrate cycle (TCA cycle) 💬[1] 67 💬
483Bempedoic acid 180mg Tablets[1] Bempedoic acid[1] Bempedoic acid 💬 [1] ACLY 💬 [1] Citrate cycle (TCA cycle) 💬[1] 79 💬
484BEN-2001----[1] 6 💬
485Benazepril[1] Benazepril[2] Benazepril hydrochloride ,
Benazepril 💬 		[1] ACE 💬 [6] Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬[5] 49, 57, 218, 222, 224 💬
486Benazepril hydrochloride 10 milligram (mg) Tab[1] Benazepril[2] Benazepril hydrochloride ,
Benazepril 💬 		[1] ACE 💬 [6] Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬[1] 218 💬
487Benazepril Hydrochloride Tablets[1] Benazepril[2] Benazepril hydrochloride ,
Benazepril 💬 		[1] ACE 💬 [6] Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬[1] 224 💬
488Benazepril Pill[1] Benazepril[2] Benazepril hydrochloride ,
Benazepril 💬 		[1] ACE 💬 [6] Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬[1] 49 💬
489Benazepril, Valsartan and Fluvastatin[3] Benazepril,
Fluvastatin,
Valsartan		[5] Valsartan ,
Benazepril hydrochloride ,
Fluvastatin sodium ,
Benazepril ,
Fluvastatin 💬 		[3] ACE,
AGTR1,
HMGCR 💬 		[22] AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Bile secretion, Calcium signaling pathway, Chagas disease, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Terpenoid backbone biosynthesis, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 218 💬
490Bendamustine[1] Bendamustine[3] Bendamustine hydrochloride ,
Bendamustine ,
Bendamustine hydrochloride hydrate 💬 		--[6] 13, 28, 49, 50, 51, 61 💬
491BENDAMUSTINE HYDROCHLORIDE[1] Bendamustine[3] Bendamustine hydrochloride ,
Bendamustine ,
Bendamustine hydrochloride hydrate 💬 		--[1] 61 💬
492Bendamustine, Rituximab[2] Bendamustine,
Rituximab		[4] Rituximab ,
Bendamustine hydrochloride ,
Bendamustine ,
Bendamustine hydrochloride hydrate 💬 		[1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 61 💬
493BENDROFLUMETHIAZIDE[1] Bendroflumethiazide[1] Bendroflumethiazide 💬 [1] SLC12A3 💬 [1] Parathyroid hormone synthesis, secretion and action 💬[1] 67 💬
494Benepali----[2] 46, 271 💬
495Benerva----[1] 8 💬
496Benidipine[1] Benidipine[2] Benidipine hydrochloride ,
Benidipine 💬 		[4] CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬 		[37] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 57 💬
497Benlysta----[7] 43, 48, 49, 53, 63, 66, 222 💬
498Benlysta (belimumab)[1] Belimumab[1] Belimumab 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[4] 11, 49, 53, 222 💬
499BENLYSTA - 120 MG - POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) 120 MG 1 FLACONCINO----[1] 53 💬
500Benlysta 400 mg powder for concentrate for solution for infusion----[2] 43, 49 💬
501Benlysta 400 mg powder for concentrate for solution for infusions----[1] 49 💬
502Benlysta 400mg polvere per concentrato per soluzione per infusione----[1] 43 💬
503BENLYSTA? (belimumab)[1] Belimumab[1] Belimumab 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
504Benlysta®----[2] 49, 222 💬
505BENLYSTA® (belimumab)[1] Belimumab[1] Belimumab 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[4] 11, 63, 66, 222 💬
506BENLYSTA™ (belimumab)[1] Belimumab[1] Belimumab 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
507Benralizumab[1] Benralizumab[1] Benralizumab 💬 [1] IL5RA 💬 [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬[5] 44, 45, 98, 162, 299 💬
508BENSERAZIDE[1] Benserazide[2] Benserazide hydrochloride ,
Benserazide 💬 		[1] DDC 💬 [8] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬[1] 6 💬
509BENSERAZIDE HYDROCHLORIDE[1] Benserazide[2] Benserazide hydrochloride ,
Benserazide 💬 		[1] DDC 💬 [8] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬[1] 6 💬
510Benzathine Penicillin----[1] 271 💬
511Benzbromaron----[1] 86 💬
512Benzbromaron AL----[1] 86 💬
513BENZBROMARONE[1] Benzbromarone[1] Benzbromarone 💬 --[1] 86 💬
514BENZILPENICILLINA BENZATINICA----[1] 62 💬
515BENZILPENICILLINA BENZATINICA BIOPHARMA - 1.200.000 UI/2.5 ML SOSPENSIONE INIETTABILE PER USO INTRAMUSCOLARE 1 SIRINGA PRERIEMPITA DA 2.5 ML----[1] 62 💬
516Benzimidazole[1] Benzimidazole---[1] 46 💬
517Benzimidazole,5-methoxy-2-[[(4-methoxy- 3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1 H-benzimidazole[1] Benzimidazole---[1] 46 💬
518Benzimidazole,5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1 H-benzimidazole[1] Benzimidazole---[1] 46 💬
519Benzofuran[1] Benzofuran---[1] 6 💬
520Benzoic acid[1] Benzoic acid[2] Benzoic acid ,
Sodium benzoate 💬 		--[1] 51 💬
521Benzoyl-L-tyrosyl-[1-13C]alanine (Bz-Tyr-Ala)[1] Alanine[1] Alanine 💬 --[1] 298 💬
522Bepranemab[1] Bepranemab[1] Bepranemab 💬 [1] MAPT 💬 [4] Alzheimer disease, MAPK signaling pathway, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬[1] 5 💬
523Berachin----[1] 6 💬
524Beraprost[1] Beraprost[2] Beraprost sodium ,
Beraprost 💬 		[1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
525Beraprost Sodium[1] Beraprost[2] Beraprost sodium ,
Beraprost 💬 		[1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
526Beraprost Sodium 314d Modified Release Tablets[1] Beraprost[2] Beraprost sodium ,
Beraprost 💬 		[1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
527Beraprost Sodium Modified Release[1] Beraprost[2] Beraprost sodium ,
Beraprost 💬 		[1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
528Berberine[1] Berberine[1] Coptis rhizome 💬 --[3] 46, 97, 265 💬
529Berberine Chloride[1] Berberine[1] Coptis rhizome 💬 --[1] 97 💬
530Beremagene geperpavec[1] Beremagene geperpavec[1] Beremagene geperpavec 💬 [1] COL7A1 💬 [2] Cornified envelope formation, Protein digestion and absorption 💬[1] 36 💬
531Berinert----[1] 65 💬
532Berinert P----[1] 65 💬
533BERINERT*IV FL 500U+FL 10ML----[1] 65 💬
534Berinert, lyophilizate for IV application containing 500 IU C1-INH to be reconstituted with 10 mL water for injection[1] Water[1] Water 💬 --[1] 65 💬
535Berinert®----[1] 65 💬
536Berinert® (C1 Esterase Inhibitor)----[1] 65 💬
537Berinert® P----[1] 65 💬
538Berinert®, 20 ??/ kg----[1] 65 💬
539BERMEKIMAB[1] Bermekimab[1] Bermekimab 💬 [1] IL1A 💬 [21] AGE-RAGE signaling pathway in diabetic complications, Alzheimer disease, Cellular senescence, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Inflammatory bowel disease, Influenza A, Leishmaniasis, MAPK signaling pathway, Measles, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Tuberculosis, Type I diabetes mellitus 💬[1] 51 💬
540BEROTRALSTAT[1] Berotralstat[2] Berotralstat ,
Berotralstat hydrochloride 💬 		[1] KLKB1 💬 [1] Complement and coagulation cascades 💬[1] 65 💬
541Bertilimumab[1] Bertilimumab---[2] 97, 162 💬
542Best Available Therapy (BAT)----[1] 13 💬
543Best Medical Therapy----[1] 97 💬
544Best Medical Treatment----[1] 6 💬
545Best medical treatment (BMT): Adjustment of the dopaminergic medication and non-dopaminergic therapy customized for each patient according to the latest published Consensus Group Recommendations----[1] 6 💬
546Best medical treatment for management of impulse control in Parkinson´s disease according to widely accepted expert consensus paper----[1] 6 💬
547Best médical treatment----[1] 6 💬
548Best oral medication----[1] 6 💬
549Best Supportive Care (BSC)----[1] 331 💬
550Beta Blocker (BB) - metoprolol, bisoprolol, carvedilol[3] Bisoprolol,
Carvedilol,
Metoprolol		[8] Carvedilol ,
Metoprolol tartrate ,
Bisoprolol fumarate ,
Metoprolol succinate ,
Bisoprolol ,
Metoprolol ,
Carvedilol phosphate ,
Metoprolol fumarate 💬 		[5] ADRA1A,
ADRA1B,
ADRA1D,
ADRB1,
ADRB2 💬 		[15] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 58 💬
551Beta carotene[1] Beta carotene[1] beta Carotene 💬 --[1] 96 💬
552Beta carotene from Dunaliella algae[1] Beta carotene[1] beta Carotene 💬 --[1] 96 💬
553Beta Hydroxybutyrate Ester (KetoneAid KE4)----[1] 2 💬
554Beta-1,3/1,6-D-Glucan----[1] 97 💬
555Beta-1b interferoni----[1] 13 💬
556Beta-Adrenergic cocktail----[1] 299 💬
557Beta-Alanine[2] Alanine,
beta-Alanine		[2] Alanine ,
beta-Alanine 💬 		--[1] 13 💬
558Beta-alanine supplementation[2] Alanine,
beta-Alanine		[2] Alanine ,
beta-Alanine 💬 		--[1] 13 💬
559Beta-Carotene----[1] 13 💬
560Beta-hydroxy-beta-methylbutyrate (HMB)----[1] 2 💬
561Beta-hydroxybuturate esters----[1] 256 💬
562Beta-Interferon----[1] 13 💬
563Beta-lactam antibiotic----[1] 299 💬
564Beta-mercaptoethylamine Hydrochloride & 2-aminoethanethiol Hydrochloride[1] Cysteamine[3] Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬 		--[1] 19 💬
565BETACAROTENE----[1] 13 💬
566BETACONNECT----[1] 13 💬
567Betaconnect auto-injector----[1] 13 💬
568BETACONNECT auto-injector.----[1] 13 💬
569Betaconnect Autoinjector----[1] 13 💬
570BETACONNECT device----[1] 13 💬
571BETAFERON----[1] 13 💬
572BETAFERON - 15 FLACONCINI 0.25 MG + 15 FLACONCINI 2 ML----[1] 13 💬
573BETAFERON 250 mcg----[1] 13 💬
574Betaferon 250 microgram/ml----[1] 13 💬
575Betaferon 250 microgram/ml, powder and solvent for solution for injection----[1] 13 💬
576Betaferon 250 microgram/mL, powder and solvent for solution for injection.----[1] 13 💬
577Betaferon 250 microgramos----[1] 13 💬
578Betaferon 250mcg----[1] 13 💬
579Betaferon 250µg----[1] 13 💬
580BETAFERON 500 mcg----[1] 13 💬
581Betaferon 500 µg----[1] 13 💬
582Betaferon 500mcg----[1] 13 💬
583Betaferon 500µg----[1] 13 💬
584BETAFERON SC 15F 0,25MG 15SIR----[1] 13 💬
585BETAFERON*15CONFEZ 0,25MG/ML+----[1] 13 💬
586Betaferon, BAY86-5046----[1] 13 💬
587Betaferon/Betaseron----[1] 13 💬
588Betaferon®----[1] 13 💬
589BETAFERON® (interferon beta-1b)[1] Interferon beta-1b[1] Interferon beta-1b 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
590Betaine[1] Betaine[3] Betaine hydrochloride ,
Betaine ,
Betaine citrate 💬 		--[4] 117, 201, 234, 337 💬
591Betaloc ZOK 100, 95 mg----[1] 113 💬
592Betaloc ZOK 25, 23,75 mg----[1] 113 💬
593BETAMETASONE----[1] 90 💬
594BETAMETASONE DOC----[1] 90 💬
595Betamethasone[1] Betamethasone[6] Betamethasone ,
Betamethasone sodium phosphate ,
Betamethasone valerate ,
Betamethasone acetate ,
Betamethasone dipropionate ,
Betamethasone benzoate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[9] 2, 28, 46, 56, 65, 83, 90, 96, 235 💬
596BETAMETHASONE ACIBUTATE[1] Betamethasone[6] Betamethasone ,
Betamethasone sodium phosphate ,
Betamethasone valerate ,
Betamethasone acetate ,
Betamethasone dipropionate ,
Betamethasone benzoate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
597Betamethasone mouthwash[1] Betamethasone[6] Betamethasone ,
Betamethasone sodium phosphate ,
Betamethasone valerate ,
Betamethasone acetate ,
Betamethasone dipropionate ,
Betamethasone benzoate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 56 💬
598Betamethasone Oral Solution Period 1 and Period 2[1] Betamethasone[6] Betamethasone ,
Betamethasone sodium phosphate ,
Betamethasone valerate ,
Betamethasone acetate ,
Betamethasone dipropionate ,
Betamethasone benzoate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 65 💬
599Betamethasone sodium phosphate/betamethasone acetate (Celestone® Soluspan®), 30 mg IM once a day for four days[2] Acetate,
Betamethasone		[6] Betamethasone ,
Betamethasone sodium phosphate ,
Betamethasone valerate ,
Betamethasone acetate ,
Betamethasone dipropionate ,
Betamethasone benzoate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 2 💬
600Betamethasone solution as intramuscular injection Period 1 and Period 2[1] Betamethasone[6] Betamethasone ,
Betamethasone sodium phosphate ,
Betamethasone valerate ,
Betamethasone acetate ,
Betamethasone dipropionate ,
Betamethasone benzoate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 65 💬
601Betaquik MCT supplement----[1] 6 💬
602Betaseron----[1] 13 💬
603Betaseron (IFN-beta-1-b, BAY86-5046, Bayer AG)----[1] 13 💬
604Betaseron (IFN-ß-1-b, BAY86-5046, Bayer AG)----[1] 13 💬
605Betaseron (Interferon beta-1b, BAY86-5046)[1] Interferon beta-1b[1] Interferon beta-1b 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
606Betaseron (Interferon beta-1b, BAY86-5046), Bayer HealthCare AG[1] Interferon beta-1b[1] Interferon beta-1b 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
607Bethanechol[1] Bethanechol[1] Bethanechol chloride 💬 [5] CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬 		[14] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬[1] 98 💬
608Bethkis----[1] 299 💬
609Bevacizumab[1] Bevacizumab[1] Bevacizumab 💬 [1] VEGFA 💬 [24] AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Integrin signaling, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
610Bevacizumab (Avastin) and Imatinib Mesylate (Gleevec)[2] Bevacizumab,
Imatinib		[3] Imatinib mesylate ,
Bevacizumab ,
Imatinib 💬 		[4] ABL1,
KIT,
PDGFRA,
VEGFA 💬 		[47] AGE-RAGE signaling pathway in diabetic complications, Acute myeloid leukemia, Axon guidance, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Glioma, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pancreatic cancer, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway, Viral myocarditis 💬[1] 87 💬
611Bevacizumab (Avastin®)[1] Bevacizumab[1] Bevacizumab 💬 [1] VEGFA 💬 [24] AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Integrin signaling, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬[1] 227 💬
612BEVACIZUMAB ZIRCONIUM ZR-89[2] Bevacizumab,
Bevacizumab zirconium Zr-89		[1] Bevacizumab 💬 [1] VEGFA 💬 [24] AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Integrin signaling, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬[1] 34 💬
613Bevacuzimab spray----[1] 227 💬
614Bevantolol[1] Bevantolol[1] Bevantolol hydrochloride 💬 [8] ADRA1A,
ADRA1B,
ADRA1D,
ADRB1,
CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬 		[44] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gap junction, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hormone signaling, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Regulation of lipolysis in adipocytes, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 8 💬
615BEVANTOLOL HYDROCHLORIDE[1] Bevantolol[1] Bevantolol hydrochloride 💬 [8] ADRA1A,
ADRA1B,
ADRA1D,
ADRB1,
CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬 		[44] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gap junction, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hormone signaling, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Regulation of lipolysis in adipocytes, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 8 💬
616BEVANTOLOLO CLORIDRATO----[1] 8 💬
617Bexarotene[1] Bexarotene[1] Bexarotene 💬 [3] RXRA,
RXRB,
RXRG 💬 		[18] Adipocytokine signaling pathway, Bile secretion, Chemical carcinogenesis - receptor activation, Efferocytosis, Gastric cancer, Hepatitis C, Lipid and atherosclerosis, Non-alcoholic fatty liver disease, Non-small cell lung cancer, PI3K-Akt signaling pathway, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer 💬[2] 13, 75 💬
618Bexicaserin[1] Bexicaserin[1] Bexicaserin 💬 [1] HTR2C 💬 [6] Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬[2] 140, 144 💬
619Bexotegrast[1] Bexotegrast[1] Bexotegrast 💬 [3] ITGA5,
ITGB1,
ITGB6 💬 		[33] Arrhythmogenic right ventricular cardiomyopathy, Axon guidance, Bacterial invasion of epithelial cells, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Leishmaniasis, Leukocyte transendothelial migration, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pertussis, Phagocytosis, Platelet activation, Proteoglycans in cancer, Rap1 signaling pathway, Regulation of actin cytoskeleton, Shigellosis, Small cell lung cancer, Tight junction, Toxoplasmosis, Virion - Herpesvirus, Virion - Rotavirus, Yersinia infection 💬[1] 94 💬
620Bexsero----[4] 11, 13, 62, 223 💬
621BEXSERO - SOSPENSIONE INIETTABILE - USO INTRAMUSCOLARE - SIRINGA P----[1] 62 💬
622BEXSERO - SOSPENSIONE INIETTABILE - USO INTRAMUSCOLARE - SIRINGA PRERIEMPITA (VETRO) - 0.5ML - 1 SIRINGA PRERIEMPITA CON AGO----[3] 62, 66, 223 💬
623Bexsero Meningococcal Group B vaccine for injection in pre-filled syringe----[1] 223 💬
624Bexsero sospensione iniettabile in siringa preriempita----[1] 62 💬
625BEXSERO – Sospensione iniettabile – Siringa preriempita----[4] 61, 62, 63, 223 💬
626Bezafibrat----[1] 93 💬
627Bezafibrat Genericon retard 400 mg----[1] 93 💬
628Bezafibrate[1] Bezafibrate[1] Bezafibrate 💬 [1] PPARA 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[8] 20, 93, 94, 160, 296, 316, 324, 344 💬
629Bezafibrate (400mg) in addition to standard 15-20 mg/kg/jour UDCA therapy[1] Bezafibrate[1] Bezafibrate 💬 [1] PPARA 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 94 💬
630Bezafibrate (drug)[1] Bezafibrate[1] Bezafibrate 💬 [1] PPARA 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 316 💬
631Bezafibrate (INN 3968)[1] Bezafibrate[1] Bezafibrate 💬 [1] PPARA 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 324 💬
632Bezafibrate 100 mg[1] Bezafibrate[1] Bezafibrate 💬 [1] PPARA 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93 💬
633Bezafibrate 200 MG[1] Bezafibrate[1] Bezafibrate 💬 [1] PPARA 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93 💬
634Bezafibrate 200 mg in addition to UDCA therapy[1] Bezafibrate[1] Bezafibrate 💬 [1] PPARA 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93 💬
635Bezafibrate 200 MG Oral Tablet[1] Bezafibrate[1] Bezafibrate 💬 [1] PPARA 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93 💬
636Bezafibrate 400 MG[1] Bezafibrate[1] Bezafibrate 💬 [1] PPARA 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93 💬
637Bezafibrate 400 mg in addition to UDCA therapy[1] Bezafibrate[1] Bezafibrate 💬 [1] PPARA 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93 💬
638Bezafibrate IR[1] Bezafibrate[1] Bezafibrate 💬 [1] PPARA 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93 💬
639Bezafibrate SR[1] Bezafibrate[1] Bezafibrate 💬 [1] PPARA 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93 💬
640Bezafibrate, Beza, BZF, Bezalip[1] Bezafibrate[1] Bezafibrate 💬 [1] PPARA 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93 💬
641Bezafibrate, Beza, BZF, Bezalip mono[1] Bezafibrate[1] Bezafibrate 💬 [1] PPARA 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93 💬
642Bezafilbrate IR----[1] 93 💬
643Bezalip----[2] 93, 94 💬
644Bezalip mono----[1] 93 💬
645Bezalip Retard----[1] 160 💬
646Bezlotoxumab[1] Bezlotoxumab[1] Bezlotoxumab 💬 --[2] 96, 97 💬
647BF 2.649----[1] 6 💬
648BF 2.649 10 mg----[1] 6 💬
649BF 2.649 20 mg----[1] 6 💬
650BF 2.649 40 mg----[1] 6 💬
651BF 2.649 5 mg----[1] 6 💬
652BF2.649----[1] 6 💬
653BF2.649 (Pitolisant)[1] Pitolisant[2] Pitolisant ,
Pitolisant hydrochloride 💬 		[1] HRH3 💬 [2] Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[1] 6 💬
654BF844[1] BF-844---[1] 303 💬
655BG-12 120----[1] 13 💬
656BG00002----[1] 13 💬
657BG00002 (natalizumab)[1] Natalizumab[1] Natalizumab 💬 [1] ITGA4 💬 [17] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13 💬
658BG00002-E (natalizumab high titer)[1] Natalizumab[1] Natalizumab 💬 [1] ITGA4 💬 [17] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13 💬
659BG00011----[1] 85 💬
660BG00012----[2] 13, 46 💬
661BG00012 (DMF)----[1] 13 💬
662BG00012 (DMF) (Tecfidera®.)----[1] 13 💬
663BG0002 (natalizumab)[1] Natalizumab[1] Natalizumab 💬 [1] ITGA4 💬 [17] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13 💬
664BG9418----[1] 13 💬
665BG9418 (interferon beta 1-a)----[1] 13 💬
666BG9418 (interferon beta-1a)[1] Interferon beta-1a[1] Interferon beta-1a 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[2] 13, 97 💬
667BG9588----[1] 223 💬
668BG9924----[2] 46, 97 💬
669BGB-45035----[1] 46 💬
670BGC20-0134----[1] 13 💬
671BGG492----[1] 13 💬
672BGJ398----[1] 238 💬
673BGJ398 (also known as BBP-831)----[1] 276 💬
674BGP-014----[1] 97 💬
675BGP-014 Capsules----[1] 97 💬
676BGX-0214----[1] 46 💬
677BH4----[2] 51, 240 💬
678BH4 20mg----[1] 299 💬
679BH4 5mg----[1] 299 💬
680BHT-3009----[1] 13 💬
681BHT-3009 0.5 mg----[1] 13 💬
682BHT-3009 1.5 mg----[1] 13 💬
683BHT-3009-01----[1] 13 💬
684BHV-0223----[1] 2 💬
685BHV-1400----[1] 66 💬
686BHV-2000----[1] 3 💬
687BHV-3241----[1] 17 💬
688BHV-4157----[1] 18 💬
689BHV-8000----[1] 6 💬
690BHV3241, verdiperstat[1] Verdiperstat[1] Verdiperstat 💬 [1] MPO 💬 [5] Acute myeloid leukemia, Drug metabolism - other enzymes, Neutrophil extracellular trap formation, Phagocytosis, Transcriptional misregulation in cancer 💬[1] 17 💬
691BI 1015550----[1] 85 💬
692BI 1015550 (Nerandomilast)[1] Nerandomilast[1] Nerandomilast 💬 [1] PDE4B 💬 [4] Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬[1] 51 💬
693BI 1015550 18 mg Film Coated Tablet----[1] 85 💬
694BI 1015550 9 mg Film Coated Tablet----[1] 85 💬
695BI 1265162----[1] 299 💬
696BI 1265162 10 µg----[1] 299 💬
697BI 1265162 100 µg----[1] 299 💬
698BI 1265162 25 µg----[1] 299 💬
699BI 1265162 50 µg----[1] 299 💬
700BI 1291583----[1] 299 💬
701BI 1323495----[1] 299 💬
702BI 1819479----[1] 85 💬
703BI 1839100----[1] 85 💬
704BI 3000202----[1] 49 💬
705BI 3032950 intravenous (Part A)----[1] 97 💬
706BI 3032950 subcutaneous (Part B)----[1] 97 💬
707BI 443651----[1] 299 💬
708BI 655064----[2] 46, 63 💬
709BI 655064 high dose----[1] 46 💬
710BI 655064 low dose----[1] 46 💬
711BI 655064 medium dose----[1] 46 💬
712BI 655066----[2] 96, 271 💬
713BI 655066 10 mg/ml----[1] 96 💬
714BI 655066 90 mg/ml----[2] 96, 271 💬
715BI 655130----[3] 37, 96, 97 💬
716BI 695500----[1] 46 💬
717BI 695501----[2] 46, 96 💬
718BI 695501 Autoinjector----[1] 46 💬
719BI 695501 Prefilled syringe----[1] 46 💬
720BI 705564----[1] 49 💬
721BI 706321----[1] 96 💬
722BI 730357----[1] 271 💬
723BI 764198----[1] 222 💬
724BI 765423----[1] 85 💬
725Bi-PegLyte----[2] 96, 97 💬
726BI-Sifrol®----[1] 6 💬
727BI655130----[1] 37 💬
728BI706321----[1] 96 💬
729BIA[1] BIA---[4] 6, 86, 96, 299 💬
730BIA 28-6156[1] BIA---[1] 6 💬
731BIA 28-6156 10 mg[1] BIA---[1] 6 💬
732BIA 28-6156 60 mg[1] BIA---[1] 6 💬
733BIA 3-202[1] BIA---[1] 6 💬
734BIA 3-202 (200 mg)[1] BIA---[1] 6 💬
735BIA 5-1058[1] BIA---[1] 86 💬
736BIA 5-1058 and Furosemide[2] BIA,
Furosemide		[1] Furosemide 💬 [1] SLC12A2 💬 [3] Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬[1] 86 💬
737BIA 6-512[1] BIA---[1] 6 💬
738BIA 6-512 100 mg[1] BIA---[1] 6 💬
739BIA 6-512 100 mg dose[1] BIA---[1] 6 💬
740BIA 6-512 200 mg dose[1] BIA---[1] 6 💬
741BIA 6-512 25 mg[1] BIA---[1] 6 💬
742BIA 6-512 25 mg dose[1] BIA---[1] 6 💬
743BIA 6-512 400 mg[1] BIA---[1] 6 💬
744BIA 6-512 50 mg dose[1] BIA---[1] 6 💬
745BIA 9-1067[1] BIA---[1] 6 💬
746BIA 9-1067 (test)[1] BIA---[1] 6 💬
747BIA 9-1067 15 mg[1] BIA---[1] 6 💬
748BIA 9-1067 25 mg[1] BIA---[1] 6 💬
749BIA 9-1067 30 mg[1] BIA---[1] 6 💬
750BIA 9-1067 5 mg[1] BIA---[1] 6 💬
751BIA 9-1067 micronized[1] BIA---[1] 6 💬
752BIA 9-1067 non-micronized[1] BIA---[1] 6 💬
753BIA-5-1058[1] BIA---[1] 86 💬
754BIAP----[2] 46, 97 💬
755Biaxin ( clarithromycin)[1] Clarithromycin[1] Clarithromycin 💬 --[1] 299 💬
756BIBF 1120----[2] 51, 85 💬
757BIBF 1120 ES----[1] 85 💬
758BIBF1120----[1] 85 💬
759BIBR 796 BS----[1] 46 💬
760BIBR 796 BS, 20 mg----[1] 96 💬
761BIBR 796 BS, 5 mg----[1] 96 💬
762Bicain spinal----[1] 46 💬
763Bicarbonate Ringer's solution----[1] 296 💬
764BICARBONATO DI SODIO----[1] 97 💬
765Bif195 capsules----[1] 96 💬
766Bifico----[1] 291 💬
767Bifidobacterium breve[1] Bifidobacterium breve---[1] 97 💬
768Bifidobacterium infantis 35624----[2] 96, 97 💬
769Bifidobacterium longum[1] Bifidobacterium longum---[2] 13, 97 💬
770BIIB014----[1] 6 💬
771BIIB017----[1] 13 💬
772BIIB017 (Peginterferon beta-1a)[1] Peginterferon beta-1a[1] Peginterferon beta-1a 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
773BIIB017 (peginterferon beta-1a) Autoinjector[1] Peginterferon beta-1a[1] Peginterferon beta-1a 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
774BIIB017 (peginterferon beta-1a) Pre-filled syringe (PFS)[1] Peginterferon beta-1a[1] Peginterferon beta-1a 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
775BIIB019----[1] 13 💬
776BIIB019 (Daclizumab High Yield Process)[1] Daclizumab[1] Daclizumab 💬 [1] IL2RA 💬 [11] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 13 💬
777BIIB019 (Daclizumab)[1] Daclizumab[1] Daclizumab 💬 [1] IL2RA 💬 [11] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 13 💬
778BIIB023----[1] 46 💬
779BIIB033----[1] 13 💬
780BIIB033 (ANTI-LINGO)----[1] 13 💬
781BIIB033 (ANTI-LINGO) - EV Substance Code SUB118957----[1] 13 💬
782BIIB033 (opicinumab)[1] Opicinumab[1] Opicinumab 💬 --[1] 13 💬
783BIIB041----[1] 13 💬
784BIIB041 (fampridine)----[1] 13 💬
785BIIB041 (Fampridine-SR)----[1] 13 💬
786BIIB041 (PR Fampridine)----[1] 13 💬
787BIIB050 / KNS-760704----[1] 2 💬
788BIIB050/KNS-760704----[1] 2 💬
789BIIB054----[1] 6 💬
790BIIB057----[1] 46 💬
791BIIB059----[1] 49 💬
792BIIB059 (litifilimab)[1] Litifilimab[1] Litifilimab 💬 --[1] 49 💬
793BIIB061----[1] 13 💬
794BIIB067----[1] 2 💬
795BIIB067 (ISIS666853)----[1] 2 💬
796BIIB067 (ISIS666853)Pharmaceutical Form: Solution for injection----[1] 2 💬
797BIIB067, QALSODY----[1] 2 💬
798BIIB078----[1] 2 💬
799BIIB091----[1] 13 💬
800BIIB092----[3] 5, 7, 127 💬
801BIIB094----[1] 6 💬
802BIIB100----[1] 2 💬
803BIIB105----[1] 2 💬
804BIIB112----[1] 90 💬
805BIIB115[1] BIIB115---[1] 3 💬
806BIIB122----[1] 6 💬
807BIIB122 225 mg----[1] 6 💬
808BIIB132----[1] 18 💬
809BIIB133----[1] 13 💬
810BIIL 283 BS (Amelubent)----[1] 299 💬
811BIIL 284 BS high dose----[1] 46 💬
812BIIL 284 BS low dose----[1] 46 💬
813BIIL 284 BS medium dose----[1] 46 💬
814BIIL 284 BS, high dose----[1] 299 💬
815BIIL 284 BS, high dose, adult patients----[1] 299 💬
816BIIL 284 BS, high dose, pediatric patients----[1] 299 💬
817BIIL 284 BS, low dose----[1] 299 💬
818BIIL 284 BS, low dose, adult patients----[1] 299 💬
819BIIL 284 BS, low dose, pediatric patients----[1] 299 💬
820BIIL 284 BS, medium dose, adult patients----[1] 299 💬
821BIIL 284 BS, medium dose, pediatric patients----[1] 299 💬
822Bilateral high frequency deep brain stimulation of the subthalamic neucleus combined with best medical treatment according to widely accepted expert consensus paper----[1] 6 💬
823Bilateral high frequency deep brainstimulation of the subthalamic nucleus combined with best medical treatment----[1] 6 💬
824Bilateral transforaminal epidural steroid injections----[1] 70 💬
825Biliary stent----[1] 300 💬
826BIM 23014----[1] 67 💬
827BIM 23A760----[1] 77 💬
828BIM23A760----[1] 77 💬
829BIM23B065----[1] 77 💬
830Bimagrumab[1] Bimagrumab[1] Bimagrumab 💬 [2] ACVR2A,
ACVR2B 💬 		[4] Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬[1] 15 💬
831Bimekizumab[1] Bimekizumab[1] Bimekizumab 💬 [2] IL17A,
IL17F 💬 		[6] Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬[5] 37, 46, 97, 107, 271 💬
832Binimetinib[1] Binimetinib[1] Binimetinib 💬 [2] MAP2K1,
MAP2K2 💬 		[90] Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cadherin signaling, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, Efferocytosis, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IgSF CAM signaling, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬[1] 34 💬
833BINOCRIT*1SIR 40000UI/1ML----[1] 18 💬
834Binyrebarkhormon----[1] 46 💬
835Binyrebsrkhormon----[1] 46 💬
836Bio-25 probiotic----[1] 299 💬
837Bio-enhanced Curcumin Soft Gelatin Capsule[2] Curcumin,
Gelatin		[1] Gelatin 💬 --[1] 97 💬
838Bio-Kult Advanced----[1] 66 💬
839BIO101----[1] 113 💬
840Bioactivated GRA for adult patients----[2] 6, 13 💬
841Bioactivated GRA for pediatric patients----[2] 6, 13 💬
842Bioactive Glass-Ceramic Spacer----[1] 70 💬
843Biocarn----[1] 3 💬
844Biochemical analysis of different bone markers.----[1] 172 💬
845Biocollection----[1] 3 💬
846Biodmards----[1] 46 💬
847Bioelectrical impedance analysis----[1] 65 💬
848Biofluid samplings----[1] 6 💬
849Biologic Agent----[2] 96, 97 💬
850Biologic Agents----[1] 46 💬
851Biologic DMARDs----[1] 107 💬
852Biologic or targeted synthetic DMARD----[2] 46, 271 💬
853Biologic therapy(eg:IFX,ADA,UST,VDZ)----[1] 97 💬
854Biologic TNFi----[1] 46 💬
855Biologic/targeted therapy----[1] 46 💬
856Biologic: IC14 (monoclonal antibody against human CD14)----[1] 2 💬
857Biological : I10E (Human normal Immunoglobulin for intravenous administration 100mg/mL)----[1] 14 💬
858Biological agents----[2] 46, 96 💬
859Biological assays----[1] 19 💬
860Biological assessment----[1] 61 💬
861Biological disease-modifying antirheumatic drugs (bDMARDs)----[1] 46 💬
862Biological DMARDs----[2] 86, 107 💬
863Biological Drug----[4] 46, 96, 97, 107 💬
864Biological NTLA-2002[1] NTLA-2002---[1] 65 💬
865Biological NTLA-3001----[1] 231 💬
866Biological samples----[1] 13 💬
867Biological sampling----[2] 65, 97 💬
868Biological samplings----[1] 96 💬
869Biological tests----[1] 63 💬
870Biological/Vaccine: Allogeneic HB-adMSCs----[1] 6 💬
871Biological: cizutamig----[1] 51 💬
872Biological: Etanercept and its biosimilars[1] Etanercept[1] Etanercept 💬 [2] LTA,
TNF 💬 		[66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 271 💬
873Biological: GB261----[1] 51 💬
874Biological: Kiovig® (Human normal Immunoglobulin for intravenous administration 100mg/mL)----[1] 14 💬
875Biological: M254----[1] 63 💬
876Biological: mesenchymal stem cell----[1] 93 💬
877Biological: SM03----[1] 46 💬
878Biological: Umbilical Cord Based Allogenic Mesenchymal Stem Cell----[1] 113 💬
879Biologically active human fecal material, OpenBiome----[1] 97 💬
880Biologically active human fecal microbiota[1] Fecal microbiota---[1] 97 💬
881Biologics----[3] 46, 96, 97 💬
882BION-1301----[1] 66 💬
883BION-1301 Multiple Doses----[1] 66 💬
884BION-1301 Single Dose----[1] 66 💬
885Bionetide----[1] 156 💬
886BIOOPA dressing----[1] 36 💬
887Biopsies----[1] 97 💬
888Biopsy----[7] 28, 34, 51, 65, 97, 193, 285 💬
889Biopsy of Colon----[1] 97 💬
890Biopsy of the labial salivary gland----[1] 53 💬
891Biopsy Procedure----[1] 65 💬
892Biosimilar----[4] 46, 96, 97, 271 💬
893Biosimilar adalimumab[1] Adalimumab[1] Adalimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 107 💬
894Biosimilar Etanercept[1] Etanercept[1] Etanercept 💬 [2] LTA,
TNF 💬 		[66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 107 💬
895Biosimilar Infliximab[1] Infliximab[1] Infliximab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[3] 46, 96, 97 💬
896Biosimilar product to adalimumab[1] Adalimumab[1] Adalimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46 💬
897Biospecimen Collection----[18] 13, 26, 28, 34, 46, 49, 50, 51, 53, 60, 62, 65, 96, 97, 159, 284, 285, 286 💬
898BioStamp nPoint device----[1] 8 💬
899BIOTIN[1] Biotin[1] Biotin 💬 --[6] 2, 8, 10, 13, 14, 20 💬
900Biotina[1] Biotin[1] Biotin 💬 --[1] 8 💬
901BIRB 796 BS, high dose----[1] 46 💬
902BIRB 796 BS, low dose----[1] 46 💬
903BIRCH BARK EXTRACT[1] Birch bark extract[1] Birch triterpenes 💬 --[1] 36 💬
904BIRT 2584 XX----[1] 13 💬
905BIRT 2584XX----[1] 13 💬
906BIRTAMIMAB[1] Birtamimab[1] Birtamimab 💬 --[1] 28 💬
907BIS-CHOLINE TETRATHIOMOLYBDATE[2] Choline,
Tetrathiomolybdate		[1] Choline 💬 --[1] 171 💬
908BIS-CHOLINE TETRATHIOMOLYBDATE, bis[(2-Hydroxyethyl)trimethylammonium] tetrathiomolybdate[2] Choline,
Tetrathiomolybdate		[1] Choline 💬 --[1] 171 💬
909Bisacodyl[1] Bisacodyl[1] Bisacodyl 💬 --[2] 13, 97 💬
910Bisoprolol[1] Bisoprolol[2] Bisoprolol fumarate ,
Bisoprolol 💬 		[1] ADRB1 💬 [13] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[5] 57, 58, 67, 86, 113 💬
911Bisoprolol Fumarate[1] Bisoprolol[2] Bisoprolol fumarate ,
Bisoprolol 💬 		[1] ADRB1 💬 [13] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 113 💬
912Bispectral Index Monitoring----[1] 70 💬
913Bisphosphonate----[1] 274 💬
914Bisphosphonate treatment----[2] 113, 299 💬
915Bisphosphonates----[2] 6, 274 💬
916Bitopertin[1] Bitopertin[1] Bitopertin 💬 [1] SLC6A9 💬 [2] Neuroactive ligand signaling, Synaptic vesicle cycle 💬[2] 254, 284 💬
917Bitopertin 10 mg[1] Bitopertin[1] Bitopertin 💬 [1] SLC6A9 💬 [2] Neuroactive ligand signaling, Synaptic vesicle cycle 💬[1] 254 💬
918Bitopertin 30 mg[1] Bitopertin[1] Bitopertin 💬 [1] SLC6A9 💬 [2] Neuroactive ligand signaling, Synaptic vesicle cycle 💬[1] 254 💬
919BITTER CANDYTUFT FRESH PLANT EXTRACT----[1] 97 💬
920Bitterschleifenblume-ganzpflanze 1,5ml/10ml----[1] 97 💬
921BIV009----[2] 61, 162 💬
922Bivigam----[1] 65 💬
923BIVV009----[1] 61 💬
924BIVV009 6.5 grams----[1] 63 💬
925BIVV009 7.5 grams----[1] 63 💬
926BIVV020----[3] 14, 61, 63 💬
927BL-7040----[1] 97 💬
928BL-8040----[1] 60 💬
929Bladder Instillation----[1] 226 💬
930Bladder instillation with heparin/ lidocaine[2] Heparin,
Lidocaine		[5] Lidocaine ,
Lidocaine hydrochloride ,
Heparin sodium ,
Heparin calcium ,
Lidocaine hydrochloride monohydrate 💬 		[7] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A,
SERPINC1 💬 		[6] Adrenergic signaling in cardiomyocytes, Cadherin signaling, Complement and coagulation cascades, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬[1] 226 💬
931Bladder instillation WITH triamcinolone acetonide[1] Triamcinolone[4] Triamcinolone ,
Triamcinolone acetonide ,
Triamcinolone diacetate ,
Triamcinolone hexacetonide 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 226 💬
932Bladder instillation WITHOUT triamcinolone acetonide[1] Triamcinolone[4] Triamcinolone ,
Triamcinolone acetonide ,
Triamcinolone diacetate ,
Triamcinolone hexacetonide 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 226 💬
933Bladder Instillations----[1] 226 💬
934Blarcamesine[1] Blarcamesine[2] Blarcamesine ,
Blarcamesine hydrochloride 💬 		[6] CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5,
SIGMAR1 💬 		[15] Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬[1] 156 💬
935BLD-2660----[1] 85 💬
936Bleomycin[1] Bleomycin[3] Bleomycin sulfate ,
Bleomycin hydrochloride ,
Bleomycin 💬 		--[4] 96, 278, 279, 280 💬
937Bleomycin + Fibrovein[1] Bleomycin[3] Bleomycin sulfate ,
Bleomycin hydrochloride ,
Bleomycin 💬 		--[1] 279 💬
938Bleomycin Baxter[1] Bleomycin[3] Bleomycin sulfate ,
Bleomycin hydrochloride ,
Bleomycin 💬 		--[1] 279 💬
939Bleselumab[1] Bleselumab[1] Bleselumab 💬 [1] CD40 💬 [17] Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Intestinal immune network for IgA production, Lipid and atherosclerosis, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Viral myocarditis 💬[1] 222 💬
940BLF----[1] 299 💬
941BLI-1300 high dose----[1] 96 💬
942BLI-1300 low dose----[1] 96 💬
943Blinatumomab[1] Blinatumomab[1] Blinatumomab 💬 [4] CD19,
CD3D,
CD3E,
CD3G 💬 		[13] B cell receptor signaling pathway, Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬[4] 11, 46, 49, 222 💬
944Blinatumomab 9ug[1] Blinatumomab[1] Blinatumomab 💬 [4] CD19,
CD3D,
CD3E,
CD3G 💬 		[13] B cell receptor signaling pathway, Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬[1] 49 💬
945Blinatumomab Treatment[1] Blinatumomab[1] Blinatumomab 💬 [4] CD19,
CD3D,
CD3E,
CD3G 💬 		[13] B cell receptor signaling pathway, Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬[1] 222 💬
946Blinded (Avatrombopoag tablets)----[1] 63 💬
947Blinded CDCA 250 mg TID----[1] 263 💬
948Blisibimod[1] Blisibimod[1] Blisibimod 💬 --[5] 43, 44, 49, 63, 66 💬
949Blisibimod Injection[1] Blisibimod[1] Blisibimod 💬 --[1] 66 💬
950Blokium 50----[1] 167 💬
951BLOKIUM 50 mg comprimidos----[1] 167 💬
952Blood----[1] 46 💬
953Blood analysis----[1] 6 💬
954Blood and fecal samples----[2] 96, 97 💬
955Blood and Marrow Transplant----[1] 20 💬
956Blood and serum samples----[1] 46 💬
957Blood and stools samples----[1] 96 💬
958Blood and urine analysis----[1] 222 💬
959Blood and urine sampling----[2] 195, 230 💬
960Blood assays----[1] 113 💬
961Blood Brain Barrier Disruption - Functional----[1] 6 💬
962Blood coagulation factor XIII----[1] 51 💬
963Blood Collection----[5] 21, 65, 201, 229, 271 💬
964Blood Collection for PK Testing (15 Mins Before Injection)----[1] 46 💬
965Blood Collection for PK Testing (15 minutes post injection)----[1] 46 💬
966Blood Collection for PK Testing (18-20 hours post injection)----[1] 46 💬
967Blood Collection for PK Testing (180 minutes post injection)----[1] 46 💬
968Blood Collection for PK Testing (60 minutes post injection)----[1] 46 💬
969Blood Collection for PK Testing (after injection)----[1] 46 💬
970Blood draw----[16] 3, 6, 13, 19, 46, 48, 49, 51, 58, 65, 67, 193, 215, 231, 298, 299 💬
971Blood draw (genetic testing)----[1] 113 💬
972Blood draw for the laboratory assessment----[2] 13, 303 💬
973Blood draw.----[2] 231, 299 💬
974Blood draw/buccal swab----[1] 331 💬
975Blood Draw/Data Collection----[1] 97 💬
976Blood drawing----[1] 81 💬
977Blood Draws----[1] 93 💬
978Blood flow restriction (BFR) and aerobic exercise via recumbent stepping (Nu-Step)----[1] 6 💬
979Blood Flow Restriction Training (BFRT)----[1] 149 💬
980Blood pressure and heart rate measurement----[1] 167 💬
981Blood pressure measurement----[1] 6 💬
982Blood Pressure-Guided Standard Hemodynamic Management----[1] 22 💬
983Blood purification equipment----[1] 13 💬
984Blood sample----[33] 2, 3, 6, 8, 10, 13, 14, 19, 34, 46, 48, 49, 51, 53, 61, 63, 65, 66, 67, 77, 79, 84, 88, 96, 97, 107, 113, 127, 195, 206, 235, 274, 299 💬
985Blood sample - venous blood 10 ml.----[1] 97 💬
986Blood sample and environmental survey----[1] 2 💬
987Blood sample collection----[4] 48, 51, 85, 111 💬
988Blood sample provided----[1] 13 💬
989Blood sample to analyse AMH level on the serum----[1] 13 💬
990Blood samples----[14] 13, 41, 46, 49, 51, 61, 63, 96, 97, 160, 167, 227, 240, 271 💬
991Blood samples collect----[1] 234 💬
992Blood samples for anti-drug antibodies----[1] 28 💬
993Blood samples for immunoglobulins----[1] 28 💬
994Blood samples for inflammatory markers----[1] 28 💬
995Blood sampling----[15] 2, 3, 13, 14, 17, 46, 51, 64, 86, 96, 97, 98, 106, 162, 300 💬
996Blood sampling and medical records----[1] 20 💬
997Blood sampling for Cholestanol Analysis----[1] 263 💬
998Blood sampling for determination of serum Zn----[1] 299 💬
999Blood sampling for dosage----[1] 19 💬
1000Blood sampling from infant----[3] 46, 96, 271 💬
1001Blood sampling from mother----[3] 46, 96, 271 💬
1002Blood sampling from umbilical cord----[3] 46, 96, 271 💬
1003Blood sampling, endoscopy----[1] 97 💬
1004Blood test----[19] 2, 6, 13, 36, 46, 49, 51, 74, 79, 83, 96, 113, 127, 162, 227, 256, 280, 299, 300 💬
1005Blood test 4 EDTA tubes----[1] 97 💬
1006Blood test analysis in the clinical labs----[1] 230 💬
1007Blood test and principal collection----[3] 46, 49, 51 💬
1008Blood test at D+3 months----[1] 227 💬
1009Blood test at D0----[1] 227 💬
1010Blood testing----[1] 13 💬
1011Blood tests----[3] 46, 226, 263 💬
1012Blood tests for full blood count, albumin, and indices of nutritional status----[1] 227 💬
1013Blood tests: IGF-1, AST/ALT/ALP/TBIL, GTT----[1] 77 💬
1014Blood withdrawal----[3] 13, 48, 65 💬
1015Blood-Brain Barrier opening with MRgFUS----[1] 2 💬
1016BLS-M22[1] BLS-M22---[1] 113 💬
1017Blue light photopheresis----[1] 96 💬
1018Blue light-absorbing sunglasses----[1] 90 💬
1019Blueberry[1] Blueberry---[2] 96, 97 💬
1020Blueberry-rich diet[1] Blueberry---[2] 96, 97 💬
1021Bluefish[1] Bluefish---[1] 58 💬
1022BLZ945----[1] 2 💬
1023BM-MSCs----[1] 71 💬
1024BM110----[1] 19 💬
1025BMB-101----[3] 140, 144, 193 💬
1026BMD003 (CFTR mRNA)----[1] 299 💬
1027BMDex----[1] 28 💬
1028BMMNC----[2] 13, 57 💬
1029BMMNCs----[1] 90 💬
1030BMN 044[1] BMN-044---[1] 113 💬
1031BMN 044 IV 6 mg/kg[1] BMN-044---[1] 113 💬
1032BMN 044 IV 9 mg/kg[1] BMN-044---[1] 113 💬
1033BMN 044 SC 6 mg/kg[1] BMN-044---[1] 113 💬
1034BMN 045[1] BMN-045---[1] 113 💬
1035BMN 053----[1] 113 💬
1036BMN 110----[1] 19 💬
1037BMN 110 - Every Other Week----[1] 19 💬
1038BMN 110 - Weekly----[1] 19 💬
1039BMN 110 Every Other Week----[1] 19 💬
1040BMN 110 Weekly----[1] 19 💬
1041BMN 111----[1] 276 💬
1042BMN 111 administration via vial and syringe----[1] 276 💬
1043BMN 165----[1] 240 💬
1044BMN 165 (rAvPAL-PEG)----[1] 240 💬
1045BMN 190----[1] 19 💬
1046BMN 250----[1] 19 💬
1047BMN 307----[1] 240 💬
1048BMN 331----[1] 65 💬
1049BMN 333----[1] 276 💬
1050BMN 349----[1] 231 💬
1051BMN 351----[1] 113 💬
1052BMN 701----[1] 256 💬
1053BMN053[1] BMN-053---[1] 113 💬
1054BMN165 20mg/day----[1] 240 💬
1055BMN165 40mg/day----[1] 240 💬
1056BMN190 recombinant human tripeptidyl peptidase-1 (rhTPP1)----[1] 19 💬
1057BMS 188667 (Abatacept)[1] Abatacept[1] Abatacept 💬 [2] CD80,
CD86 💬 		[14] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬[1] 13 💬
1058BMS Drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin)[5] Digoxin,
Flurbiprofen,
Midazolam,
Montelukast,
Omeprazole		[11] Digoxin ,
Flurbiprofen ,
Omeprazole ,
Montelukast sodium ,
Midazolam ,
Midazolam hydrochloride ,
Omeprazole sodium ,
Flurbiprofen sodium ,
Midazolam maleate ,
Omeprazole magnesium ,
Montelukast 💬 		[25] ATP1A1,
ATP1A2,
ATP1A3,
ATP1A4,
ATP4A,
ATP4B,
CYSLTR1,
GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ,
PTGS1,
PTGS2 💬 		[52] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Arachidonic acid metabolism, Bile secretion, C-type lectin receptor signaling pathway, Cadherin signaling, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Chemical carcinogenesis - DNA adducts, Collecting duct acid secretion, Cytoskeleton in muscle cells, Efferocytosis, Endocrine and other factor-regulated calcium reabsorption, GABAergic synapse, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Insulin secretion, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, Mineral absorption, Morphine addiction, NF-kappa B signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pancreatic secretion, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, Taste transduction, Thyroid hormone signaling pathway, Thyroid hormone synthesis, VEGF signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 46 💬
1059BMS-188667----[10] 46, 49, 53, 65, 96, 97, 107, 222, 223, 271 💬
1060BMS-232632----[1] 265 💬
1061BMS-582949[1] BMS-582949---[1] 46 💬
1062BMS-582949 and Methotrexate[2] BMS-582949,
Methotrexate		[2] Methotrexate ,
Methotrexate sodium 💬 		[2] DHFR,
DHFR2 💬 		[3] Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬[1] 46 💬
1063BMS-817399[1] BMS-817399---[1] 46 💬
1064BMS-931699[1] Lulizumab pegol---[3] 49, 53, 160 💬
1065BMS-936557----[2] 96, 97 💬
1066BMS-936557 (Anti-IP-10 Antibody)----[1] 96 💬
1067BMS-945429[1] Clazakizumab[1] Clazakizumab 💬 --[2] 46, 96 💬
1068BMS-986004----[1] 63 💬
1069BMS-986004 1500 mg IV----[1] 63 💬
1070BMS-986004 225 mg IV----[1] 63 💬
1071BMS-986004 675 mg IV----[1] 63 💬
1072BMS-986004 75 mg IV----[1] 63 💬
1073BMS-986020[1] BMS-986020---[2] 51, 85 💬
1074BMS-986089----[1] 113 💬
1075BMS-986089-01 (RO7239361) , anti-myostatin----[1] 113 💬
1076BMS-986089-01 (RO7239361) Injections, 15 mg/Syringe (21.4 mg/mL)----[1] 113 💬
1077BMS-986089-01 (RO7239361) Injections, 35 mg/Syringe (50 mg/mL)----[1] 113 💬
1078BMS-986089-01 (RO7239361) Injections, 50 mg/Syringe (71.4 mg/mL)----[1] 113 💬
1079BMS-986089-01 (RO7239361) Injections, 7.5 mg/Syringe (10.7 mg/mL)----[1] 113 💬
1080BMS-986089-01 (RO7239361), anti-myostatin----[1] 113 💬
1081BMS-986089-01 Injections, 15 mg/Syringe (21.4 mg/mL)----[1] 113 💬
1082BMS-986089-01 Injections, 35 mg/Syringe (50 mg/mL)----[1] 113 💬
1083BMS-986089-01 Injections, 50 mg/Syringe (71.4 mg/mL)----[1] 113 💬
1084BMS-986089-01 Injections, 7.5 mg/Syringe (10.7 mg/mL)----[1] 113 💬
1085BMS-986089-01, Anti-myostatin----[1] 113 💬
1086BMS-986104[1] BMS-986104---[1] 46 💬
1087BMS-986142[1] BMS-986142---[3] 46, 53, 160 💬
1088BMS-986142 200mg[1] BMS-986142---[1] 46 💬
1089BMS-986142 350mg[1] BMS-986142---[1] 46 💬
1090BMS-986165----[3] 49, 96, 97 💬
1091BMS-986165 Capsule----[1] 49 💬
1092BMS-986165 Tablet----[1] 49 💬
1093BMS-986166----[1] 97 💬
1094BMS-986168----[1] 5 💬
1095BMS-986184----[1] 97 💬
1096BMS-986195[1] Branebrutinib[1] Branebrutinib 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[3] 46, 49, 53 💬
1097BMS-986251[1] BMS-986251---[2] 46, 271 💬
1098BMS-986256[1] Afimetoran[1] Afimetoran 💬 --[1] 49 💬
1099BMS-986256-06, TLR7/8 Antagonist[1] Afimetoran[1] Afimetoran 💬 --[1] 49 💬
1100BMS-986278[1] BMS-986278[1] Admilparant 💬 [1] LPAR1 💬 [8] Gap junction, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Regulation of actin cytoskeleton 💬[1] 85 💬
1101BMS-986278Product Code: BMS-986278Pharmaceutical Form: Film-coated tabletINN or Proposed INN: LPA1Current Sponsor code: BMS-986278Other descriptive name: BMS-986278Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 10-Pharmaceutical form of the placebo: Film-coated tabletRoute of administration of the placebo: Oral useProduct Name: BMS-986278Product Code: BMS-986278Pharmaceutical Form: Film-coated tabletINN or Proposed INN: LPA1Current Sponsor code: BMS-986278Other descriptive name: BMS-986278Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 30-Pharmaceutical form of the placebo: Film-coated tabletRoute of administration of the placebo: Oral use----[1] 85 💬
1102BMS-986325----[1] 53 💬
1103BMS-986326----[1] 49 💬
1104BMS-986353----[3] 51, 61, 63 💬
1105BMS-986368----[1] 13 💬
1106BMS-986374----[1] 13 💬
1107BMS-986413----[2] 63, 64 💬
1108BMS-986414----[2] 63, 64 💬
1109BMS-986454----[1] 46 💬
1110BMS-986528----[1] 46 💬
1111BMS-9894923----[1] 6 💬
1112BMS188667----[1] 46 💬
1113BMS356384----[1] 79 💬
1114BMS986142----[3] 46, 53, 160 💬
1115BMS986165----[2] 96, 97 💬
1116BMS986168----[1] 5 💬
1117BMS986195----[3] 46, 49, 53 💬
1118BN82451B----[1] 8 💬
1119BN8251B----[1] 8 💬
1120BNJ441----[1] 66 💬
1121BNP blood sample test----[1] 58 💬
1122BNT162----[1] 13 💬
1123BNT162b2----[7] 13, 35, 46, 49, 50, 51, 107 💬
1124BNT162b2, Bivalent----[7] 13, 35, 46, 49, 50, 51, 107 💬
1125Bocidelpar[1] Bocidelpar[2] Bocidelpar ,
Bocidelpar sulfate 💬 		[1] PPARG 💬 [12] AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[1] 113 💬
1126Bococizumab[1] Bococizumab[1] Bococizumab 💬 [1] PCSK9 💬 [1] Cholesterol metabolism 💬[1] 79 💬
1127Bococizumab (PF-04950615[1] Bococizumab[1] Bococizumab 💬 [1] PCSK9 💬 [1] Cholesterol metabolism 💬[1] 79 💬
1128BodyBio Balance Oil----[1] 13 💬
1129BodyBio PC----[1] 13 💬
1130Bof-, Mazelen-, Rubellavaccin, poeder voor injectievloeistof----[1] 107 💬
1131Bone balance measurements----[1] 81 💬
1132Bone densitometry----[2] 49, 162 💬
1133Bone marrow ablation with stem cell support----[2] 28, 60 💬
1134Bone Marrow Aspirate----[1] 60 💬
1135Bone Marrow Aspiration----[7] 28, 60, 62, 65, 284, 285, 286 💬
1136Bone Marrow Aspiration and Biopsy----[3] 28, 34, 60 💬
1137Bone marrow autologous mesenchymal stem cells transplantation----[1] 13 💬
1138Bone Marrow Biopsy----[7] 26, 28, 60, 62, 65, 284, 286 💬
1139Bone Marrow Concentrate----[1] 70 💬
1140Bone marrow derived mesenchymal stem cells----[2] 6, 60 💬
1141Bone Marrow Derived Mesenchymal Stem cells (MSCs)----[1] 96 💬
1142Bone marrow derived mononuclear cells and G-CSF----[1] 57 💬
1143Bone marrow infusion----[1] 36 💬
1144Bone marrow mesenchymal stem cells----[1] 85 💬
1145Bone marrow mononuclear cell infusion----[1] 71 💬
1146Bone marrow mononuclear cells----[1] 57 💬
1147Bone marrow or umbilical cord blood (UCG) stem cell transplantation----[1] 36 💬
1148Bone Marrow Stimulation----[1] 57 💬
1149Bone Marrow Transplant----[2] 60, 274 💬
1150Bone marrow transplantation----[4] 51, 60, 284, 285 💬
1151Bone marrow-derived mesenchymal stem cells----[1] 298 💬
1152Bone marrow-derived mesenchymal stromal cells (MSCs)----[1] 274 💬
1153Bonefos----[1] 274 💬
1154BoNT-A----[1] 6 💬
1155Bony Toxicity----[1] 34 💬
1156Bood and urine sampling----[1] 265 💬
1157BOOST cells----[1] 274 💬
1158Boost VHC----[1] 299 💬
1159Boostrix®----[1] 46 💬
1160Boots High Strength Garlic Odour Controlled[1] Garlic[1] Garlic 💬 --[1] 299 💬
1161BORAGE OIL[1] Borage oil---[1] 13 💬
1162BORAGE OIL 20% GLA[1] Borage oil---[1] 13 💬
1163Borage seed oil----[1] 46 💬
1164BORTEZOMIB[1] Bortezomib[1] Bortezomib 💬 [1] PSMB5 💬 [8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[19] 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 172, 222, 223, 228, 256, 283, 288, 331 💬
1165Bortezomib (drug)[1] Bortezomib[1] Bortezomib 💬 [1] PSMB5 💬 [8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 28 💬
1166Bortezomib (Velcade®)[1] Bortezomib[1] Bortezomib 💬 [1] PSMB5 💬 [8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 66 💬
1167Bortezomib Accord[1] Bortezomib[1] Bortezomib 💬 [1] PSMB5 💬 [8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 28 💬
1168Bortezomib D-mannitol[3] Bortezomib,
Bortezomib D-mannitol,
Mannitol		[2] Mannitol ,
Bortezomib 💬 		[1] PSMB5 💬 [8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 28 💬
1169Bortezomib Injection[1] Bortezomib[1] Bortezomib 💬 [1] PSMB5 💬 [8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 64 💬
1170Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab[3] Bortezomib,
Daratumumab,
Dexamethasone		[5] Dexamethasone ,
Dexamethasone sodium phosphate ,
Bortezomib ,
Dexamethasone phosphate ,
Daratumumab 💬 		[3] CD38,
NR3C1,
PSMB5 💬 		[15] Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia 💬[1] 28 💬
1171Bortezomib/dexamethasone[2] Bortezomib,
Dexamethasone		[4] Dexamethasone ,
Dexamethasone sodium phosphate ,
Bortezomib ,
Dexamethasone phosphate 💬 		[2] NR3C1,
PSMB5 💬 		[9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 283 💬
1172Bortezomib/Dexamethasone (BD), Followed By Autologous STC & Maintenance Bortezomib/Dexamethasone[2] Bortezomib,
Dexamethasone		[4] Dexamethasone ,
Dexamethasone sodium phosphate ,
Bortezomib ,
Dexamethasone phosphate 💬 		[2] NR3C1,
PSMB5 💬 		[9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 28 💬
1173BOS161721----[1] 49 💬
1174Bosentan[1] Bosentan[2] Bosentan ,
Bosentan 💬 		[2] EDNRA,
EDNRB 💬 		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[12] 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
1175Bosentan (Tracleer)[1] Bosentan[2] Bosentan ,
Bosentan 💬 		[2] EDNRA,
EDNRB 💬 		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 51 💬
1176Bosentan 125 mg[1] Bosentan[2] Bosentan ,
Bosentan 💬 		[2] EDNRA,
EDNRB 💬 		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 51 💬
1177Bosentan 62.5 mg[1] Bosentan[2] Bosentan ,
Bosentan 💬 		[2] EDNRA,
EDNRB 💬 		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 51 💬
1178Bosentan administration[1] Bosentan[2] Bosentan ,
Bosentan 💬 		[2] EDNRA,
EDNRB 💬 		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
1179Bosentan and dapagliflozin[2] Bosentan,
Dapagliflozin		[3] Bosentan ,
Bosentan ,
Dapagliflozin 💬 		[2] EDNRA,
EDNRB 💬 		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[2] 40, 41 💬
1180Bosentan Dispersible Tablets[1] Bosentan[2] Bosentan ,
Bosentan 💬 		[2] EDNRA,
EDNRB 💬 		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
1181Bosentan group[1] Bosentan[2] Bosentan ,
Bosentan 💬 		[2] EDNRA,
EDNRB 💬 		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 51 💬
1182Bosentan monohydrat[1] Bosentan[2] Bosentan ,
Bosentan 💬 		[2] EDNRA,
EDNRB 💬 		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
1183BOSENTAN MONOHYDRATE[1] Bosentan[2] Bosentan ,
Bosentan 💬 		[2] EDNRA,
EDNRB 💬 		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[4] 51, 84, 86, 88 💬
1184BOSENTAN MYLAN[1] Bosentan[2] Bosentan ,
Bosentan 💬 		[2] EDNRA,
EDNRB 💬 		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 41 💬
1185Bosentan, Ambrisentan[2] Ambrisentan,
Bosentan		[3] Bosentan ,
Ambrisentan ,
Bosentan 💬 		[2] EDNRA,
EDNRB 💬 		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
1186Bosutinib[1] Bosutinib[2] Bosutinib ,
Bosutinib hydrate 💬 		[2] ABL1,
SRC 💬 		[50] Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Chronic myeloid leukemia, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Hormone signaling, Human cytomegalovirus infection, IgSF CAM signaling, Inflammatory mediator regulation of TRP channels, Integrin signaling, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬[2] 2, 67 💬
1187Bosutinib (anhydrous)[1] Bosutinib[2] Bosutinib ,
Bosutinib hydrate 💬 		[2] ABL1,
SRC 💬 		[50] Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Chronic myeloid leukemia, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Hormone signaling, Human cytomegalovirus infection, IgSF CAM signaling, Inflammatory mediator regulation of TRP channels, Integrin signaling, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬[1] 67 💬
1188Bosutinib (Phase 1 part)[1] Bosutinib[2] Bosutinib ,
Bosutinib hydrate 💬 		[2] ABL1,
SRC 💬 		[50] Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Chronic myeloid leukemia, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Hormone signaling, Human cytomegalovirus infection, IgSF CAM signaling, Inflammatory mediator regulation of TRP channels, Integrin signaling, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬[1] 2 💬
1189Bosutinib (Phase 2 part)[1] Bosutinib[2] Bosutinib ,
Bosutinib hydrate 💬 		[2] ABL1,
SRC 💬 		[50] Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Chronic myeloid leukemia, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Hormone signaling, Human cytomegalovirus infection, IgSF CAM signaling, Inflammatory mediator regulation of TRP channels, Integrin signaling, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬[1] 2 💬
1190BOSWELAN----[1] 13 💬
1191Boswellia serrata extract PS0201Bo capsules----[1] 13 💬
1192Boswellic acids (BOSWELAN)----[1] 13 💬
1193Botaretigene Sparoparvovec[1] Botaretigene sparoparvovec---[1] 90 💬
1194BOTOX----[5] 6, 13, 36, 149, 226 💬
1195BOTOX 100 UNITES ALLERGAN (PR1)----[1] 2 💬
1196Botox 100 UNT Injection----[1] 13 💬
1197BOTOX 100U in normal saline----[1] 226 💬
1198BOTOX 200U in normal saline----[1] 226 💬
1199Botox injection----[2] 2, 47 💬
1200BOTOX®----[1] 13 💬
1201BOTOX® solution----[1] 51 💬
1202Botulinic toxin----[1] 36 💬
1203Botulinum A toxin----[1] 118 💬
1204Botulinum Neurotoxin----[1] 226 💬
1205Botulinum Toxin----[3] 6, 13, 149 💬
1206Botulinum toxin A----[2] 13, 226 💬
1207BOTULINUM TOXIN A - HAEMAGGLUTININ COMPLEX[1] Botulinum toxin type A[4] Botulinum toxin type A ,
OnabotulinumtoxinA ,
AbobotulinumtoxinA ,
Incobotulinumtoxin A 💬 		[1] SNAP25 💬 [2] Insulin secretion, Synaptic vesicle cycle 💬[1] 13 💬
1208Botulinum toxin application----[1] 149 💬
1209BOTULINUM TOXIN TYPE A[1] Botulinum toxin type A[4] Botulinum toxin type A ,
OnabotulinumtoxinA ,
AbobotulinumtoxinA ,
Incobotulinumtoxin A 💬 		[1] SNAP25 💬 [2] Insulin secretion, Synaptic vesicle cycle 💬[13] 2, 5, 6, 7, 13, 15, 17, 47, 70, 113, 149, 171, 226 💬
1210Botulinum toxin type A (Botox®, Allergan)[1] Botulinum toxin type A[4] Botulinum toxin type A ,
OnabotulinumtoxinA ,
AbobotulinumtoxinA ,
Incobotulinumtoxin A 💬 		[1] SNAP25 💬 [2] Insulin secretion, Synaptic vesicle cycle 💬[1] 149 💬
1211Botulinum toxin type A (Nabota®) injection into the gastrocnemius muscle[1] Botulinum toxin type A[4] Botulinum toxin type A ,
OnabotulinumtoxinA ,
AbobotulinumtoxinA ,
Incobotulinumtoxin A 💬 		[1] SNAP25 💬 [2] Insulin secretion, Synaptic vesicle cycle 💬[1] 70 💬
1212Botulinum Toxin Type A 200U[1] Botulinum toxin type A[4] Botulinum toxin type A ,
OnabotulinumtoxinA ,
AbobotulinumtoxinA ,
Incobotulinumtoxin A 💬 		[1] SNAP25 💬 [2] Insulin secretion, Synaptic vesicle cycle 💬[1] 13 💬
1213Botulinum Toxin Type A 300U[1] Botulinum toxin type A[4] Botulinum toxin type A ,
OnabotulinumtoxinA ,
AbobotulinumtoxinA ,
Incobotulinumtoxin A 💬 		[1] SNAP25 💬 [2] Insulin secretion, Synaptic vesicle cycle 💬[1] 13 💬
1214Botulinum toxin type A injection[1] Botulinum toxin type A[4] Botulinum toxin type A ,
OnabotulinumtoxinA ,
AbobotulinumtoxinA ,
Incobotulinumtoxin A 💬 		[1] SNAP25 💬 [2] Insulin secretion, Synaptic vesicle cycle 💬[1] 6 💬
1215Botulinum toxin type B[1] Botulinum toxin type B[1] RimabotulinumtoxinB 💬 [1] SNAP25 💬 [2] Insulin secretion, Synaptic vesicle cycle 💬[3] 2, 6, 51 💬
1216Botulinum toxin type B (2500 units / vial)[1] Botulinum toxin type B[1] RimabotulinumtoxinB 💬 [1] SNAP25 💬 [2] Insulin secretion, Synaptic vesicle cycle 💬[1] 51 💬
1217Botulinum toxin type B (Myobloc)[1] Botulinum toxin type B[1] RimabotulinumtoxinB 💬 [1] SNAP25 💬 [2] Insulin secretion, Synaptic vesicle cycle 💬[2] 2, 6 💬
1218Botulinum toxin(Botox)----[1] 51 💬
1219Botulinum Toxin: Xeomin----[1] 6 💬
1220Botulism Toxin Treatment----[1] 161 💬
1221Bouchard Belgian Dark Chocolate Probiotic Napolitains, containing bifidobacterium longum[1] Bifidobacterium longum---[1] 13 💬
1222Boulardii----[2] 96, 97 💬
1223Bovine intesastinal alkaline phosphatase (bIAP)[1] Alkaline Phosphatase---[1] 46 💬
1224Bovine intestinal alkaline phosphatase (BIAP)[1] Alkaline Phosphatase---[1] 97 💬
1225Bovine type I collagen[1] Bovine type I collagen---[1] 51 💬
1226Bovine-Calf Alkaline Phosphatase (BIAP)[1] Alkaline Phosphatase---[1] 97 💬
1227Bovine-Calf Alkaline Phosphatase BIAP[1] Alkaline Phosphatase---[1] 97 💬
1228BOW015----[1] 46 💬
1229Boya IVIG----[1] 65 💬
1230BP-SCIG 20%----[1] 65 💬
1231BPAN Patients----[1] 121 💬
1232BPN14770----[1] 206 💬
1233BPN14770/ zatolmilast[1] Zatolmilast[1] Zatolmilast 💬 [1] PDE4D 💬 [4] Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬[1] 206 💬
1234BPR277----[1] 160 💬
1235BPR277 ointment----[1] 160 💬
1236BPR277 ointment (controlled application)----[1] 160 💬
1237BPS-314d-MR----[1] 86 💬
1238BPS-MR----[1] 86 💬
1239BPS804----[2] 172, 274 💬
1240BPS804, UX143----[1] 274 💬
1241BPX-501----[3] 60, 285, 326 💬
1242BPX-501 cells----[3] 60, 285, 326 💬
1243BPX-501 T cells----[4] 65, 284, 285, 326 💬
1244BQ123----[1] 17 💬
1245BR-DIM----[1] 49 💬
1246BR9001----[1] 46 💬
1247BR900A----[1] 46 💬
1248Brain Magnetic Resonance Imaging (MRI)----[1] 17 💬
1249Brain MRI----[1] 8 💬
1250Brain MRI/MRS/fMRI----[1] 19 💬
1251Brain PET scan----[3] 5, 7, 127 💬
1252BRAMICIL - 100 MG/ 2 ML SOLUZIONE INIETTABILE 10 FIALE DA 2 ML----[1] 299 💬
1253Bramitob----[1] 299 💬
1254BRAMITOB - 300 MG/4 ML SOLUZIONE DA NEBULIZZARE 56 CONTENITORI MONODOSE 4 ML----[1] 299 💬
1255Bramitob 300mg/4ml Nebuliser Solution----[1] 299 💬
1256BRAMITOB*NEBUL 28F 300MG/4ML----[1] 299 💬
1257BRAMITOB*NEBUL 56F 300MG/4ML----[1] 299 💬
1258Bramitob® administered by PARI eFlow® rapid electronic nebulizer----[1] 299 💬
1259Bramitob® administered by PARI LC® PLUS nebulizer----[1] 299 💬
1260Branaplam[1] Branaplam[1] Branaplam 💬 --[2] 3, 8 💬
1261Branebrutinib[1] Branebrutinib[1] Branebrutinib 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[3] 46, 49, 53 💬
1262BRAZIKUMAB[1] Brazikumab[1] Brazikumab 💬 [1] IL23A 💬 [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬[2] 96, 97 💬
1263Brazikumab high dose[1] Brazikumab[1] Brazikumab 💬 [1] IL23A 💬 [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬[1] 96 💬
1264Brazikumab Induction Dose[1] Brazikumab[1] Brazikumab 💬 [1] IL23A 💬 [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬[2] 96, 97 💬
1265Brazikumab IV Infusion[1] Brazikumab[1] Brazikumab 💬 [1] IL23A 💬 [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬[1] 96 💬
1266Brazikumab low dose[1] Brazikumab[1] Brazikumab 💬 [1] IL23A 💬 [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬[1] 96 💬
1267Brazikumab Maintenance Dose[1] Brazikumab[1] Brazikumab 💬 [1] IL23A 💬 [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬[2] 96, 97 💬
1268Brazikumab SC Injection[1] Brazikumab[1] Brazikumab 💬 [1] IL23A 💬 [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬[1] 96 💬
1269BrazikumabProduct Code: MEDI2070Pharmaceutical Form: Solution for injection/infusion in pre-filled syringeINN or Proposed INN: BRAZIKUMABCAS Number: 1610353-18-8Other descriptive name: Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human Monoclonal Antibody----[1] 97 💬
1270Breast Milk Sample Collection----[1] 96 💬
1271Breast milk sampling----[4] 46, 96, 97, 271 💬
1272Breath Test----[1] 285 💬
1273Bredinin tablet 150mg----[1] 46 💬
1274Bredinin tablet 50mg----[1] 46 💬
1275Breelib nebulizer----[1] 86 💬
1276Brensocatib[1] Brensocatib[1] Brensocatib 💬 [1] CTSC 💬 [2] Apoptosis, Lysosome biogenesis 💬[1] 299 💬
1277Brensocatib 10 mg[1] Brensocatib[1] Brensocatib 💬 [1] CTSC 💬 [2] Apoptosis, Lysosome biogenesis 💬[1] 299 💬
1278Brensocatib 25 mg[1] Brensocatib[1] Brensocatib 💬 [1] CTSC 💬 [2] Apoptosis, Lysosome biogenesis 💬[1] 299 💬
1279Brentuximab[1] Brentuximab---[2] 49, 51 💬
1280Brentuximab vedotin[2] Brentuximab,
Brentuximab vedotin		[1] Brentuximab vedotin 💬 [10] TNFRSF8,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		[13] Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, IgSF CAM signaling, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬[2] 49, 51 💬
1281Brepocitinib[1] Brepocitinib[1] Brepocitinib 💬 [2] JAK1,
TYK2 💬 		[27] Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[5] 49, 50, 84, 96, 97 💬
1282Brepocitinib 25 mg[1] Brepocitinib[1] Brepocitinib 💬 [2] JAK1,
TYK2 💬 		[27] Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[2] 96, 97 💬
1283Brepocitinib 5 mg[1] Brepocitinib[1] Brepocitinib 💬 [2] JAK1,
TYK2 💬 		[27] Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[2] 96, 97 💬
1284Brepocitinib 5mg[1] Brepocitinib[1] Brepocitinib 💬 [2] JAK1,
TYK2 💬 		[27] Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 96 💬
1285Brigatinib[1] Brigatinib[1] Brigatinib 💬 [1] ALK 💬 [3] Non-small cell lung cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer 💬[1] 34 💬
1286Brimonidine[1] Brimonidine[2] Brimonidine tartrate ,
Brimonidine 💬 		[3] ADRA2A,
ADRA2B,
ADRA2C 💬 		[4] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[2] 13, 90 💬
1287Brimonidine tartrate[1] Brimonidine[2] Brimonidine tartrate ,
Brimonidine 💬 		[3] ADRA2A,
ADRA2B,
ADRA2C 💬 		[4] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[2] 13, 90 💬
1288Brimonidine Tartrate Posterior Segment Drug Delivery System (Brimo PS DDS) Applicator System[1] Brimonidine[2] Brimonidine tartrate ,
Brimonidine 💬 		[3] ADRA2A,
ADRA2B,
ADRA2C 💬 		[4] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 90 💬
1289Brincidofovir[1] Brincidofovir[1] Brincidofovir 💬 --[1] 25 💬
1290Brineura----[1] 19 💬
1291Brintellix----[1] 6 💬
1292BRINTELLIX - 20 MG/ML - GOCCE ORALI, SOLUZIONE - USO ORALE - FLACONE (VETRO) 15 ML - 1 FLACONE----[1] 6 💬
1293Brivaracetam[1] Brivaracetam[1] Brivaracetam 💬 [1] SV2A 💬 [1] ECM-receptor interaction 💬[2] 149, 309 💬
1294Brivaracetam 25 mg[1] Brivaracetam[1] Brivaracetam 💬 [1] SV2A 💬 [1] ECM-receptor interaction 💬[1] 309 💬
1295Brivaracetam 50 mg[1] Brivaracetam[1] Brivaracetam 💬 [1] SV2A 💬 [1] ECM-receptor interaction 💬[1] 309 💬
1296Brivekimig----[2] 222, 223 💬
1297BRL-049653----[1] 46 💬
1298BRL-301----[4] 48, 49, 51, 53 💬
1299Broccoli[1] Broccoli---[3] 36, 97, 299 💬
1300Broccoli sprouts[1] Broccoli---[1] 299 💬
1301Brodalumab[1] Brodalumab[1] Brodalumab 💬 [1] IL17RA 💬 [3] Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway 💬[2] 37, 51 💬
1302Brodalumab 210mg SC[1] Brodalumab[1] Brodalumab 💬 [1] IL17RA 💬 [3] Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway 💬[1] 37 💬
1303Bromlein----[2] 94, 97 💬
1304Bromocriptin----[1] 74 💬
1305Bromocriptin 2.5mg, 2-3 times a day----[1] 74 💬
1306BROMOCRIPTINE[1] Bromocriptine[2] Bromocriptine mesylate ,
Bromocriptine 💬 		[2] DRD2,
PRL 💬 		[14] Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬[3] 6, 57, 74 💬
1307Bromocriptine and other dopamine agonists[2] Bromocriptine,
Dopamine		[4] Dopamine hydrochloride ,
Bromocriptine mesylate ,
Bromocriptine ,
Dopamine 💬 		[6] DRD1,
DRD2,
DRD3,
DRD4,
DRD5,
PRL 💬 		[17] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
1308BROMOCRIPTINE MESILATE[1] Bromocriptine[2] Bromocriptine mesylate ,
Bromocriptine 💬 		[2] DRD2,
PRL 💬 		[14] Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 74 💬
1309Bromocriptine mesylate plus standard GDMT[1] Bromocriptine[2] Bromocriptine mesylate ,
Bromocriptine 💬 		[2] DRD2,
PRL 💬 		[14] Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 57 💬
1310Bromocriptine mesylate tablets[1] Bromocriptine[2] Bromocriptine mesylate ,
Bromocriptine 💬 		[2] DRD2,
PRL 💬 		[14] Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 74 💬
1311Bromure d'Ipratropium[1] Ipratropium---[1] 86 💬
1312Bronchial mucus collection----[1] 299 💬
1313Bronchitol----[1] 299 💬
1314Bronchoalveolar lavage (BAL fluid)----[2] 49, 51 💬
1315Bronchoalveolar lavage fluid collection----[1] 229 💬
1316Bronchodilator Response----[1] 294 💬
1317Bronchoscopic brushing----[1] 228 💬
1318Bronchoscopy----[1] 84 💬
1319Bronchoscopy with bronchoalveolar lavage----[1] 84 💬
1320BRS201----[2] 94, 97 💬
1321BRV 2.5 mg----[1] 309 💬
1322BRV 25 mg----[1] 309 💬
1323BRV 50 mg----[1] 309 💬
1324BRX-345----[2] 2, 15 💬
1325Bryostatin 1[1] Bryostatin 1---[2] 13, 62 💬
1326BS01----[1] 90 💬
1327BSF 208075----[1] 86 💬
1328BSF 208075 or LU 208075----[1] 86 💬
1329BT-11----[2] 96, 97 💬
1330BT-11 (440 mg)----[1] 97 💬
1331BT-11 (880 mg)----[1] 97 💬
1332BT-11 1000mg----[2] 96, 97 💬
1333BT-11 500 mg----[2] 96, 97 💬
1334BT-11 880 mg----[1] 96 💬
1335BT-11 high----[1] 98 💬
1336BT-11 low----[1] 98 💬
1337BT051 200 mg----[1] 97 💬
1338BT051 3200 mg----[1] 97 💬
1339BT051 800 mg----[1] 97 💬
1340BT061----[1] 46 💬
1341BT061 (CD4 monoclonal antibody)----[1] 46 💬
1342BT063----[1] 49 💬
1343BT090----[1] 65 💬
1344BT200[1] BT200---[1] 288 💬
1345BT524----[1] 65 💬
1346BT595----[2] 63, 65 💬
1347BT681----[1] 65 💬
1348BT971----[1] 46 💬
1349BTK Inhibitor----[3] 46, 53, 160 💬
1350BTRX-246040[1] BTRX-246040---[1] 6 💬
1351BTT-1023----[1] 46 💬
1352BTT1023----[1] 94 💬
1353BTT1023 IV Infusion 20 mg/mL, 5 mL Drug Product----[1] 94 💬
1354Bu Zhong Yi Qi Tang----[1] 11 💬
1355Bu Zhong Yi Qi Tang, Zhi Xue Tang, Chuan xin lian kang yan pian mod, Tian Wang Bu xin Dan----[1] 63 💬
1356Buccal (cheek) swab----[2] 89, 158 💬
1357Bucelipase alfa[1] Bucelipase alfa---[1] 299 💬
1358Bucillamine[1] Bucillamine[1] Bucillamine 💬 --[1] 46 💬
1359Buckwheat[1] Buckwheat---[1] 226 💬
1360Bucladesine[1] Bucladesine[1] Bucladesine 💬 [16] PDE10A,
PDE11A,
PDE1A,
PDE1B,
PDE1C,
PDE2A,
PDE3A,
PDE3B,
PDE4A,
PDE4B,
PDE4C,
PDE4D,
PDE7A,
PDE7B,
PDE8A,
PDE8B 💬 		[17] Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 246 💬
1361Budenofalk----[1] 96 💬
1362Budenofalk 2mg rectal foam----[1] 97 💬
1363Budenofalk 3mg----[2] 93, 97 💬
1364Budenofalk 3mg gastro-resistant capsules----[1] 96 💬
1365Budenofalk 9mg gastro-resistant granules----[1] 96 💬
1366Budenofalk rectal foam----[1] 97 💬
1367Budenofalk® suppositories----[1] 97 💬
1368Budenofalk® suppositories (BUS)----[1] 97 💬
1369Budesonid----[1] 95 💬
1370BUDESONIDE[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[10] 66, 93, 94, 95, 96, 97, 98, 223, 228, 299 💬
1371Budesonide (6 mg)[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
1372Budesonide (9 mg)[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
1373Budesonide 0.5 mg compresse orodispersibili[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
1374Budesonide 0.5 mg orodispersible tablets[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
1375Budesonide 0.5mg orodispersible tablet twice daily[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
1376Budesonide 1 mg compresse orodispersibili[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
1377Budesonide 1 mg orodispersible tablets[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
1378Budesonide 1 mg orodispersible tablets (BUL 1 mg)[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
1379Budesonide 1mg orodispersible tablet twice daily[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
1380Budesonide 2 mg orodispersible tablets (BUL 2 mg)[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
1381Budesonide 6 mg prolonged-release capsule, hard (BUX-PVII prototype)[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
1382Budesonide 6 mg prolonged-release capsules, hard (BUX-PVII prototype)[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
1383Budesonide 9 mg capsules, hard (BUX-PV)[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
1384Budesonide 9 mg prolonged-release capsule, hard (BUX-PVII prototype)[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
1385Budesonide 9 mg prolonged-release capsules, hard (BUX-PVII prototype)[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
1386Budesonide [0.4mg/ml] viscous suspension[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
1387Budesonide Gel[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
1388Budesonide MMX[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
1389Budesonide MMX 6 mg Tablet[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
1390Budesonide MMX®[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
1391Budesonide MMX® 6 mg[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
1392Budesonide MMX® 9 mg[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
1393Budesonide oral suspension[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
1394Budesonide oral suspension [0.2 mg/ml][1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
1395Budesonide Orodispersible Tablets (Jorveza)[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
1396Budesonide plus Prevacid[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
1397Budesonide-formoterol single inhaler[2] Budesonide,
Formoterol		[3] Budesonide ,
Formoterol fumarate ,
Formoterol 💬 		[2] ADRB2,
NR3C1 💬 		[11] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 299 💬
1398Budesonide-MMX[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
1399Budesonide-MMX®[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
1400Budesonide-MMX® 6 mg[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
1401Budesonide-MMX® 9 mg[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
1402Budesonide-MMX™[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
1403Budesonide/formoterol[2] Budesonide,
Formoterol		[3] Budesonide ,
Formoterol fumarate ,
Formoterol 💬 		[2] ADRB2,
NR3C1 💬 		[11] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 228 💬
1404Budezonide----[1] 96 💬
1405Budoprutug[1] Budoprutug---[3] 49, 63, 222 💬
1406BUET 0.5 mg----[1] 98 💬
1407BUET 1 mg----[1] 98 💬
1408BUET 1mg----[1] 98 💬
1409BUET 2mg----[1] 98 💬
1410BUL 0.5 mg----[1] 98 💬
1411BUL 1 mg----[1] 98 💬
1412Buloxibutid[1] Buloxibutid[2] Buloxibutid ,
Buloxibutid sodium 💬 		[2] AGTR1,
AGTR2 💬 		[17] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 85 💬
1413BUMEKIZUMAB----[1] 46 💬
1414Bumetanide[1] Bumetanide[1] Bumetanide 💬 [1] SLC12A2 💬 [3] Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬[4] 6, 57, 115, 158 💬
1415Bumetanide white, oblong, scored tablet[1] Bumetanide[1] Bumetanide 💬 [1] SLC12A2 💬 [3] Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬[1] 6 💬
1416Buntanetap----[1] 6 💬
1417Buntanetap Tartrate [(+)-phenserine D-tartrate][1] Phenserine---[1] 6 💬
1418Buntanetap/posiphen[1] Posiphen[1] Buntanetap 💬 [1] ACHE 💬 [3] Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬[1] 6 💬
1419BUPI5----[1] 53 💬
1420Bupivacaine[1] Bupivacaine[2] Bupivacaine hydrochloride ,
Bupivacaine 💬 		[6] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		[5] Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬[10] 46, 51, 53, 70, 71, 96, 97, 168, 226, 298 💬
1421BUPIVACAINE HYDROCHLORIDE[1] Bupivacaine[2] Bupivacaine hydrochloride ,
Bupivacaine 💬 		[6] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		[5] Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬[2] 46, 53 💬
1422Bupivacaine hydrochloride 0.5% (Marcaine, Pfizer)[1] Bupivacaine[2] Bupivacaine hydrochloride ,
Bupivacaine 💬 		[6] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		[5] Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬[1] 46 💬
1423Bupivacaine Injection 0.5%[1] Bupivacaine[2] Bupivacaine hydrochloride ,
Bupivacaine 💬 		[6] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		[5] Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬[1] 168 💬
1424Bupivacaine, triamcinolone, and heparin (BTH)[3] Bupivacaine,
Heparin,
Triamcinolone		[8] Triamcinolone ,
Triamcinolone acetonide ,
Triamcinolone diacetate ,
Triamcinolone hexacetonide ,
Bupivacaine hydrochloride ,
Heparin sodium ,
Heparin calcium ,
Bupivacaine 💬 		[8] NR3C1,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A,
SERPINC1 💬 		[7] Adrenergic signaling in cardiomyocytes, Cadherin signaling, Complement and coagulation cascades, Dopaminergic synapse, IgSF CAM signaling, Neuroactive ligand-receptor interaction, Taste transduction 💬[1] 226 💬
1425Bupivacaine-Epinephrine 0.25%-1:200,000 Injectable Solution plus clonidine[3] Bupivacaine,
Clonidine,
Epinephrine		[7] Epinephrine ,
Clonidine ,
Clonidine hydrochloride ,
Epinephrine hydrochloride ,
Bupivacaine hydrochloride ,
Epinephrine bitartrate ,
Bupivacaine 💬 		[15] ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		[20] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Cadherin signaling, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Hormone signaling, IgSF CAM signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 70 💬
1426Bupivacaine/epinephrine/dexamethasone[3] Bupivacaine,
Dexamethasone,
Epinephrine		[8] Epinephrine ,
Dexamethasone ,
Dexamethasone sodium phosphate ,
Epinephrine hydrochloride ,
Bupivacaine hydrochloride ,
Epinephrine bitartrate ,
Bupivacaine ,
Dexamethasone phosphate 💬 		[16] ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3,
NR3C1,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		[20] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Cadherin signaling, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Hormone signaling, IgSF CAM signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 96 💬
1427Bupivacaïne HCl 0,125% / Sufentanil 50 µg flacon à 50 ml[1] Sufentanil[2] Sufentanil citrate ,
Sufentanil 💬 		[1] OPRM1 💬 [5] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[1] 70 💬
1428Bupivicaine alone----[1] 298 💬
1429Bupizenge----[1] 53 💬
1430Bupleurum+Ginkgo----[1] 6 💬
1431Buprenorphine[1] Buprenorphine[2] Buprenorphine hydrochloride ,
Buprenorphine 💬 		[2] OPRK1,
OPRM1 💬 		[5] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[3] 46, 70, 298 💬
1432Buprenorphine Transdermal Patch[1] Buprenorphine[2] Buprenorphine hydrochloride ,
Buprenorphine 💬 		[2] OPRK1,
OPRM1 💬 		[5] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[1] 46 💬
1433Bupropion[1] Bupropion[3] Bupropion hydrochloride ,
Bupropion ,
Bupropion hydrobromide 💬 		[2] SLC6A2,
SLC6A3 💬 		[8] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬[7] 8, 18, 21, 96, 97, 171, 298 💬
1434Bupropion & Citalopram[2] Bupropion,
Citalopram		[5] Bupropion hydrochloride ,
Citalopram hydrobromide ,
Bupropion ,
Citalopram ,
Bupropion hydrobromide 💬 		[3] SLC6A2,
SLC6A3,
SLC6A4 💬 		[9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle 💬[1] 18 💬
1435Bupropion 150 mg twice daily[1] Bupropion[3] Bupropion hydrochloride ,
Bupropion ,
Bupropion hydrobromide 💬 		[2] SLC6A2,
SLC6A3 💬 		[8] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬[1] 298 💬
1436Bupropion Hydrochloride[1] Bupropion[3] Bupropion hydrochloride ,
Bupropion ,
Bupropion hydrobromide 💬 		[2] SLC6A2,
SLC6A3 💬 		[8] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬[1] 171 💬
1437Bupropion-SR[1] Bupropion[3] Bupropion hydrochloride ,
Bupropion ,
Bupropion hydrobromide 💬 		[2] SLC6A2,
SLC6A3 💬 		[8] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬[1] 97 💬
1438Burfiralimab[1] Burfiralimab---[1] 46 💬
1439Burlulipase[1] Burlulipase---[1] 299 💬
1440Burosumab[1] Burosumab[1] Burosumab 💬 [1] FGF23 💬 [11] Breast cancer, Calcium signaling pathway, Gastric cancer, MAPK signaling pathway, Melanoma, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton 💬[1] 238 💬
1441Bushen quhan zhiwang decoction----[1] 46 💬
1442BUSILVEX----[4] 19, 36, 60, 65 💬
1443BUSILVEX - 6 MG/ML - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO - 10 ML 8 FLACONCINI----[2] 19, 65 💬
1444Buspirone[1] Buspirone[2] Buspirone hydrochloride ,
Buspirone 💬 		[2] DRD2,
HTR1A 💬 		[12] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬[3] 6, 51, 179 💬
1445BUSPIRONE CLORIDRATO[1] Buspirone[2] Buspirone hydrochloride ,
Buspirone 💬 		[2] DRD2,
HTR1A 💬 		[12] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬[1] 6 💬
1446Buspirone Hydrochloride[1] Buspirone[2] Buspirone hydrochloride ,
Buspirone 💬 		[2] DRD2,
HTR1A 💬 		[12] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬[1] 6 💬
1447Busulfan[1] Busulfan[1] Busulfan 💬 --[14] 19, 20, 28, 34, 36, 49, 51, 60, 65, 164, 274, 284, 285, 326 💬
1448Busulfan test dose[1] Busulfan[1] Busulfan 💬 --[1] 65 💬
1449Busulfan, Cyclophosphamide, Antithymocyte Globulin[2] Busulfan,
Cyclophosphamide		[3] Busulfan ,
Cyclophosphamide ,
Cyclophosphamide 💬 		--[2] 19, 20 💬
1450Busulfan, Cyclophosphamide, ATG[2] Busulfan,
Cyclophosphamide		[3] Busulfan ,
Cyclophosphamide ,
Cyclophosphamide 💬 		--[1] 19 💬
1451Busulfan, Cyclophosphamide, ATG, GCSF[2] Busulfan,
Cyclophosphamide		[3] Busulfan ,
Cyclophosphamide ,
Cyclophosphamide 💬 		--[2] 65, 284 💬
1452Busulfan, Cyclophosphamide, Thymoglobulin, Fludarabine (Conditioning regimen)[3] Busulfan,
Cyclophosphamide,
Fludarabine		[5] Busulfan ,
Cyclophosphamide ,
Fludarabine phosphate ,
Cyclophosphamide ,
Fludarabine 💬 		[1] RRM1 💬 [4] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬[1] 326 💬
1453Busulfan, fludarabine, & cyclophosphamide with immunosuppression with ATG and cyclosporine.[4] Busulfan,
Cyclophosphamide,
Cyclosporine,
Fludarabine		[6] Cyclosporine ,
Busulfan ,
Cyclophosphamide ,
Fludarabine phosphate ,
Cyclophosphamide ,
Fludarabine 💬 		[6] PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2,
RRM1 💬 		[37] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Drug metabolism - other enzymes, Glucagon signaling pathway, Glutamatergic synapse, Glutathione metabolism, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Pyrimidine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[2] 60, 285 💬
1454Busulfan, Fludarabine, ATG, TLI[2] Busulfan,
Fludarabine		[3] Busulfan ,
Fludarabine phosphate ,
Fludarabine 💬 		[1] RRM1 💬 [4] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬[2] 65, 284 💬
1455Busulfan/Fludarabine phosphate/Tacrolimus/Methotrexate/G-CSF[4] Busulfan,
Fludarabine,
Methotrexate,
Tacrolimus		[7] Tacrolimus ,
Methotrexate ,
Busulfan ,
Fludarabine phosphate ,
Methotrexate sodium ,
Fludarabine ,
Tacrolimus 💬 		[8] DHFR,
DHFR2,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2,
RRM1 💬 		[40] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Drug metabolism - other enzymes, Folate biosynthesis, Folate transport and metabolism, Glucagon signaling pathway, Glutamatergic synapse, Glutathione metabolism, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, One carbon pool by folate, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Pyrimidine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[1] 60 💬
1456BUSULFANO----[1] 19 💬
1457Butylphthalide[1] Butylphthalide---[4] 2, 6, 17, 22 💬
1458Butyrate----[2] 46, 97 💬
1459Butyrate enemas + routine management----[1] 291 💬
1460Butyric Acid[1] Butyric Acid[1] Sodium butyrate 💬 --[1] 222 💬
1461BUU 0.4mg/ml----[1] 98 💬
1462BV-101----[1] 8 💬
1463BVEC----[1] 36 💬
1464BVS857----[1] 1 💬
1465BW-20805----[1] 65 💬
1466BX-1----[1] 13 💬
1467BX004----[1] 299 💬
1468BX004-A----[1] 299 💬
1469BXD treatment----[1] 97 💬
1470By demand----[2] 96, 97 💬
1471BYDUREON----[2] 6, 17 💬
1472Bydureon 2 mg powder and solvent for prolonged-release suspension----[1] 6 💬
1473Byetta----[2] 78, 193 💬
1474Byetta 5 micrograms----[1] 6 💬
1475BYM338----[1] 15 💬
1476BYM338 (Bimagrumab)[1] Bimagrumab[1] Bimagrumab 💬 [2] ACVR2A,
ACVR2B 💬 		[4] Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬[1] 15 💬
1477BYM338/bimagrumab[1] Bimagrumab[1] Bimagrumab 💬 [2] ACVR2A,
ACVR2B 💬 		[4] Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬[1] 15 💬
1478Béfizal----[1] 302 💬
1479Bélimumab----[1] 63 💬